var title_f25_56_26496="Subcorneal pustular dermatosis";
var content_f25_56_26496=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68679&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68679&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Subcorneal pustular dermatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 260px; height: 272px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Annular pustular dermatosis affecting predominantly flexural areas and causing post-inflammatory pigmentation in a patient with subcorneal pustular dermatosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Samuel Moschella, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26496=[""].join("\n");
var outline_f25_56_26496=null;
var title_f25_56_26497="Calculator: Systemic Vascular Resistance";
var content_f25_56_26497=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"SystemicVascRes_form\" name=\"SystemicVascRes_form\" onkeydown=\"clrResults();\" onkeyup=\"SystemicVascRes_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Systemic Vascular Resistance",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <table cellpadding=\"10\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"      <tr>",
"       <td align=\"left\" bgcolor=\"#6c9a9c\">",
"        <span class=\"medCalcFontFormuli\">",
"         SVR = 80 * ( MeanAorticPressure - RightAtrialPressure) / SystemicFlow",
"        </span>",
"       </td>",
"      </tr>",
"     </table>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"      <tr>",
"       <td align=\"right\" width=\"50%\">",
"        <center>",
"         <span class=\"medCalcFontIO\">",
"          Input:",
"         </span>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"          <tr>",
"           <td align=\"right\" width=\"42%\">",
"            <span class=\"medCalcFontOneBold\">",
"             Mean Aortic Pressure",
"            </span>",
"           </td>",
"           <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"            &nbsp;",
"            <input name=\"Mean_Aortic_Pressure_param\" onblur=\"SystemicVascRes_fx(); minMaxCheck();\" onchange=\"SystemicVascRes_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"           </td>",
"           <td align=\"left\" valign=\"top\" width=\"115\">",
"            <select class=\"medCalcFontSelect\" name=\"Mean_Aortic_Pressure_unit\" onchange=\"SystemicVascRes_fx();\" style=\"width:105px;\">",
"             <option value=\"0.00750063755419211|0|Pascal\">",
"              Pascal",
"             </option>",
"             <option value=\"760.002100178515|0|atm\">",
"              atm",
"             </option>",
"             <option value=\"750.063755419211|0|bar\">",
"              bar",
"             </option>",
"             <option value=\"0.735561538478802|0|cmH2O\">",
"              cmH2O",
"             </option>",
"             <option value=\"10|0|cmHg\">",
"              cmHg",
"             </option>",
"             <option value=\"22.4199156928339|0|ftH2O\">",
"              ftH2O",
"             </option>",
"             <option value=\"0.735561538478802|0|gm/sqcm\">",
"              gm/sqcm",
"             </option>",
"             <option value=\"1.86832630773616|0|inH2O\">",
"              inH2O",
"             </option>",
"             <option value=\"25.4000840071406|0|inHg\">",
"              inHg",
"             </option>",
"             <option value=\"7.50063755419211|0|kPa\">",
"              kPa",
"             </option>",
"             <option value=\"0.750063755419211|0|mbar\">",
"              mbar",
"             </option>",
"             <option selected=\"selected\" value=\"1|0|mmHg\">",
"              mmHg",
"             </option>",
"             <option value=\"51.7150957831416|0|psi\">",
"              psi",
"             </option>",
"             <option value=\"1|0|torr\">",
"              torr",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"right\" width=\"42%\">",
"            <span class=\"medCalcFontOneBold\">",
"             Right Atrial Pressure",
"            </span>",
"           </td>",
"           <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"            &nbsp;",
"            <input name=\"Right_Atrial_Pressure_param\" onblur=\"SystemicVascRes_fx(); minMaxCheck();\" onchange=\"SystemicVascRes_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"           </td>",
"           <td align=\"left\" valign=\"top\" width=\"115\">",
"            <select class=\"medCalcFontSelect\" name=\"Right_Atrial_Pressure_unit\" onchange=\"SystemicVascRes_fx();\" style=\"width:105px;\">",
"             <option value=\"0.00750063755419211|0|Pascal\">",
"              Pascal",
"             </option>",
"             <option value=\"760.002100178515|0|atm\">",
"              atm",
"             </option>",
"             <option value=\"750.063755419211|0|bar\">",
"              bar",
"             </option>",
"             <option value=\"0.735561538478802|0|cmH2O\">",
"              cmH2O",
"             </option>",
"             <option value=\"10|0|cmHg\">",
"              cmHg",
"             </option>",
"             <option value=\"22.4199156928339|0|ftH2O\">",
"              ftH2O",
"             </option>",
"             <option value=\"0.735561538478802|0|gm/sqcm\">",
"              gm/sqcm",
"             </option>",
"             <option value=\"1.86832630773616|0|inH2O\">",
"              inH2O",
"             </option>",
"             <option value=\"25.4000840071406|0|inHg\">",
"              inHg",
"             </option>",
"             <option value=\"7.50063755419211|0|kPa\">",
"              kPa",
"             </option>",
"             <option value=\"0.750063755419211|0|mbar\">",
"              mbar",
"             </option>",
"             <option selected=\"selected\" value=\"1|0|mmHg\">",
"              mmHg",
"             </option>",
"             <option value=\"51.7150957831416|0|psi\">",
"              psi",
"             </option>",
"             <option value=\"1|0|torr\">",
"              torr",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td align=\"right\" width=\"42%\">",
"            <span class=\"medCalcFontOneBold\">",
"             Systemic Flow",
"            </span>",
"           </td>",
"           <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"            &nbsp;",
"            <input name=\"Systemic_Flow_param\" onblur=\"SystemicVascRes_fx(); minMaxCheck();\" onchange=\"SystemicVascRes_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"           </td>",
"           <td align=\"left\" valign=\"top\" width=\"115\">",
"            <select class=\"medCalcFontSelect\" name=\"Systemic_Flow_unit\" onchange=\"SystemicVascRes_fx();\" style=\"width:105px;\">",
"             <option selected=\"selected\" value=\"1|0|L/min\">",
"              L/min",
"             </option>",
"             <option value=\"60|0|L/sec\">",
"              L/sec",
"             </option>",
"             <option value=\"1.666666667e-05|0|mL/hr\">",
"              mL/hr",
"             </option>",
"             <option value=\"0.001|0|mL/min\">",
"              mL/min",
"             </option>",
"             <option value=\"0.06|0|mL/sec\">",
"              mL/sec",
"             </option>",
"            </select>",
"           </td>",
"          </tr>",
"         </table>",
"        </center>",
"       </td>",
"       <td align=\"left\" bgcolor=\"#eeeeee\">",
"        <center>",
"         <span class=\"medCalcFontIO\">",
"          Result:",
"         </span>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"          <tr>",
"           <td align=\"right\">",
"            <span class=\"medCalcFontOneBold\">",
"             SVR",
"            </span>",
"           </td>",
"           <td nowrap=\"nowrap\" valign=\"top\">",
"            &nbsp;",
"            <input name=\"SVR_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"           </td>",
"           <td valign=\"top\">",
"            <span class=\"medCalcFontOne\">",
"             <span style=\"white-space: nowrap;\">",
"              <span class=\"medCalcFontOneBold\">",
"               dynes-sec-cm",
"               <sup>",
"                -5",
"               </sup>",
"              </span>",
"             </span>",
"            </span>",
"           </td>",
"          </tr>",
"          <tr>",
"           <td colspan=\"3\">",
"            &nbsp;",
"            <br/>",
"           </td>",
"          </tr>",
"         </table>",
"        </center>",
"       </td>",
"      </tr>",
"     </table>",
"    </center>",
"    <div class=\"notes\">",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       In most cases",
"       <b>",
"        Systemic Flow",
"       </b>",
"       is equivalent to the cardiac output.",
"      </li>",
"      <li>",
"       Normal",
"       <b>",
"        SVR",
"       </b>",
"       is approximately 1170 +- 270 dynes-sec-cm",
"       <sup>",
"        -5",
"       </sup>",
"       .",
"      </li>",
"      <li>",
"       In most cases the",
"       <b>",
"        Mean Aortic Pressure",
"       </b>",
"       is equivalent to the mean arterial pressure, which can be obtained from most hemodynamic monitors.",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div class=\"references\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Baim D, ed.",
"        <i>",
"         Grossman's Cardiac Catheterization, Angiography, and Intervention",
"        </i>",
"        . Lipincott Williams &amp; Wilkins 7th Ed. 2006.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Barratt-Boyes BG, Wood EH. Cardiac output and related measurements and pressure values in the right heart and associated vessels,  together with an analysis of the hemo-dynamic response to the inhalation of high oxygen mixtures in healthy subjects.",
"        <i>",
"         J Lab Clin Med",
"        </i>",
"        . 1958 Jan;51(1):72-90.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26497=[" /* <![CDATA[ */",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function SystemicVascRes_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.SystemicVascRes_form){",
"",
"",
"doCalc = true;",
"if (Mean_Aortic_Pressure_param.value.indexOf(',') >= 0){ Mean_Aortic_Pressure_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Mean_Aortic_Pressure_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Mean_Aortic_Pressure_unit.options[Mean_Aortic_Pressure_unit.selectedIndex].value.split('|');",
"Mean_Aortic_Pressure = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Right_Atrial_Pressure_param.value.indexOf(',') >= 0){ Right_Atrial_Pressure_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Right_Atrial_Pressure_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Right_Atrial_Pressure_unit.options[Right_Atrial_Pressure_unit.selectedIndex].value.split('|');",
"Right_Atrial_Pressure = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Systemic_Flow_param.value.indexOf(',') >= 0){ Systemic_Flow_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Systemic_Flow_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Systemic_Flow_unit.options[Systemic_Flow_unit.selectedIndex].value.split('|');",
"Systemic_Flow = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = 0;",
"SVR =  80 * ( Mean_Aortic_Pressure - Right_Atrial_Pressure) / Systemic_Flow;",
"",
"if (doCalc) SVR_param.value = fixDP(SVR, dp);",
"",
"",
"",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.SystemicVascRes_form){",
"",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.SystemicVascRes_form){",
"",
"SVR_param.value = '';",
"",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"/* ]]> */"].join("\n");
var outline_f25_56_26497=null;
var title_f25_56_26498="Completed axillary dissection";
var content_f25_56_26498=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F63143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F63143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 502px\">",
"   <div class=\"ttl\">",
"    Completed axillary dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 482px; height: 425px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Completed axillary lymph node dissection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26498=[""].join("\n");
var outline_f25_56_26498=null;
var title_f25_56_26499="Ceftaroline: Patient drug information";
var content_f25_56_26499=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ceftaroline: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4628?source=see_link\">",
"     see \"Ceftaroline: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F11390165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Teflaro&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F11426157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691487",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F11426149\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3009903",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ceftaroline or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F11426151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F11426160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals and good mouth care may help. Older children may suck hard, sugar-free candy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F11426153\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F11426159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F11426150\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F11426161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store as you have been told by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F11426154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16089 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-180.241.123.62-8D972B75FE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26499=[""].join("\n");
var outline_f25_56_26499=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11390165\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11426157\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11426149\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11426151\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11426160\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11426153\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11426159\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11426150\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11426161\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11426154\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4628?source=related_link\">",
"      Ceftaroline: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_56_26500="Pegvisomant acromegaly IGF1";
var content_f25_56_26500=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F66653&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F66653&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Effect of pegvisomant on serum IGF-1 concentrations",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 332px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Results in 90 patients with acromegaly who were treated with the growth hormone receptor antagonist pegvisomant for 12 to 24 months. The open circles represent the pretreatment values and the closed circles the lowest post-treatment values. The shaded areas represent the normal ranges for age.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: van der Lely, AJ, Hutson, RK, Trainer, PJ, et al. Lancet 2001; 358:1754.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26500=[""].join("\n");
var outline_f25_56_26500=null;
var title_f25_56_26501="ECG strip sinus bradycardia";
var content_f25_56_26501=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52675&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52675&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1130px;\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Single lead electrocardiogram (ECG) showing sinus bradycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 79px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Marked sinus bradycardia at a rate of 25 to 30 beats/min. The normal P waves (upright in lead II) and PR interval and consistent with a sinus mechanism with normal atrioventricular (AV) conduction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26501=[""].join("\n");
var outline_f25_56_26501=null;
var title_f25_56_26502="Follicular small cleaved NHL";
var content_f25_56_26502=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F74837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F74837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Follicular lymphoma grade I (follicular small cleaved cell lymphoma)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This neoplastic lymph node follicle is composed almost entirely of small cleaved cells with indented, angulated nuclear membranes and very little cytoplasm (centrocytes). A small population of large, noncleaved cells (centroblasts, red arrow) can also be seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Warnke, RA, Weiss, LM, Chan, JK, Cleary, ML, Dorfman, RF. Tumors of the lymph nodes and spleen. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 14, 1995, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26502=[""].join("\n");
var outline_f25_56_26502=null;
var title_f25_56_26503="Bartonellosis: Oroya fever and verruga peruana";
var content_f25_56_26503=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bartonellosis: Oroya fever and verruga peruana",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/56/26503/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/56/26503/contributors\">",
"     David H Spach, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/56/26503/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/56/26503/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/56/26503/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/56/26503/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/56/26503/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 8, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bartonellosis, or Carrion's disease, is a biphasic disease caused by Bartonella bacilliformis and transmitted by sandflies of the genus Phlebotomus.",
"   </p>",
"   <p>",
"    The disease is characterized by an initial life-threatening febrile phase known as Oroya fever followed by an eruptive phase known as verruga peruana. In the late 1800s, Daniel Carrion, a courageous Peruvian medical student, linked these two phases of the disease as caused by the same organism by inoculating himself with material from skin lesions in a patient with verruga peruana and soon thereafter developed a fatal case of Oroya fever.",
"   </p>",
"   <p>",
"    Information on Bartonella infection in HIV-infected patients is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since 1992, 22 Bartonella species or subspecies have been identified; three of these species cause the majority of Bartonella-associated infections in humans. One of these species, Bartonella bacilliformis, is a small, gram-negative, intracellular bacterium that is the causative organism of Oroya fever and verruga peruana.",
"   </p>",
"   <p>",
"    In 2007, investigators identified a new Bartonella species from a patient who had fever and splenomegaly after traveling to a region in Peru, where B. bacilliformis is endemic [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/1\">",
"     1",
"    </a>",
"    ]. After a fastidious bacterium was isolated from the patient's blood, it was initially assumed the patient had Oroya fever secondary to infection with B. bacilliformis. Genetic analyses, however, demonstrated that the bacterium represented a previously uncultured Bartonella species (B. rochalimaea). It is possible that some cases of Oroya fever, which were attributed to B. bacilliformis, may be due to this closely related species.",
"   </p>",
"   <p>",
"    Other Bartonella species and their clinical manifestations are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=see_link\">",
"     \"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36583?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Bartonella quintana infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/5/31830?source=see_link\">",
"     \"Endocarditis caused by Bartonella\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29879?source=see_link\">",
"     \"Basic biology of Bartonella species\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;B. bacilliformis invades human red blood cells to cause disease. High parasitism of the red blood cells leads to their removal from the circulation and acute anemia, a cause of death in Oroya fever [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/2\">",
"     2",
"    </a>",
"    ]. In addition to red blood cells, the organism invades endothelial cells.",
"   </p>",
"   <p>",
"    The verruga lesions are formed by proliferation of capillaries and endothelial cell hyperplasia and are similar to those seen in cutaneous bacillary angiomatosis and Kaposi's sarcoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18009?source=see_link\">",
"     \"AIDS-related Kaposi sarcoma: Staging and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bartonellosis is endemic to certain areas of the Andean regions of Peru, Columbia, and Ecuador, referred to as the \"verruga zone.\" The geographic limitation seems to be related to the environmental requirements of the vector, Lutzomyia verrucarum, a sand fly. There is evidence from pre-Columbian artifacts that the cutaneous form of the disease was present in Ecuador at least 1000 years prior to the arrival of Europeans [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The occurrence of the disease outside of the verruga zone, in areas where L. verrucarum is not the dominant sand fly species, suggests differences in the vector responsible for transmission.",
"   </p>",
"   <p>",
"    A number of atypical illnesses characterized only by chronic verrucous skin lesions (phase two of classic bartonellosis) were reported to occur in the coastal lowland province of Manabi between 1987 and 1995 [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/4\">",
"     4",
"    </a>",
"    ]. An investigation of 11 clinical cases and a serologic study of 224 persons in the surrounding region found a 21 percent seropositivity among contacts of index cases, suggesting that bartonellosis is significantly underreported due to the existence of mild clinical disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients who develop Oroya fever are tourists and transient workers who are immunologically-naive to B. bacilliformis, whereas most cases of verruga peruana involve native populations in the Andes.",
"   </p>",
"   <p>",
"    In a population-based prospective cohort investigation in an endemic region of Peru, the highest rates of infection were in children less than five years of age (38 cases per 100 person-years); the incidence in the general population was 12.7 cases of bartonellosis (either Oroya fever [11 percent], verruga peruana and a recent febrile illness suggestive of Oroya fever [37 percent], or verruga peruana without a recent febrile illness [32 percent], or asymptomatic infection [21 percent]) per 100 person-years [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors identified on multivariate analysis included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age (RR 0.96 per each year of life, 95% CI, 0.95-0.98)",
"     </li>",
"     <li>",
"      Household case density (RR 2.63, 95% CI, 2.1-3.3)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection with B. bacilliformis causes an array of clinical manifestations, including an acute febrile illness known as Oroya fever and a chronic cutaneous phase known as verruga peruana [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Less than 40 percent of patients who develop verruga peruana lesions recall a history of febrile illness in the prior three months [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/5,7\">",
"     5,7",
"    </a>",
"    ]. Serologic surveys indicate that as many as 56 percent of seropositive individuals have asymptomatic infection [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Acute phase (Oroya fever)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acute or hematic phase usually begins about three weeks after inoculation, typically with an insidious onset of mild fever, headache, anorexia, and malaise, lasting from several days to several weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/6\">",
"     6",
"    </a>",
"    ]. At this stage, patients may develop anemia as a consequence of the B. bacilliformis organisms parasitizing erythrocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective review of bartonellosis in Peru examined 145 symptomatic patients in whom bartonellosis was diagnosed from 1969 through 1992 [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/7\">",
"     7",
"    </a>",
"    ]. The most common clinical features of patients in the acute phase were fever, pallor, malaise, painless hepatomegaly, and lymphadenopathy. In the acute phase, the B. bacilliformis organisms presumably disseminate throughout the body, enter erythrocytes and cells of the reticuloendothelial system, and cause rapid development of anemia.",
"   </p>",
"   <p>",
"    Overall, nearly 70 percent of patients with acute bartonellosis have complications, including infectious and noninfectious problems [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/7\">",
"     7",
"    </a>",
"    ]. The infectious complications are primarily superinfection with Salmonella spp, Shigella, Staphylococcus aureus, or Enterobacter spp. The most common noninfectious problems were anasarca, neurologic manifestations, and pericardial effusion.",
"   </p>",
"   <p>",
"    Although the factors that determine the severity of the clinical illness have not been clearly elucidated, the inoculum size of the organism, specific organism virulence factors, nutritional status of the host, and the host's immune response to B. bacilliformis all may play a role [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If untreated, the more severe form of Oroya fever is associated with a greater than 40 percent mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/5,9\">",
"     5,9",
"    </a>",
"    ]. In those who recover, symptoms dissipate and anemia subsides after two to three weeks. More severe disease and higher fatality rates are associated with secondary infectious complications, particularly with Salmonella septicemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Verruga peruana",
"    </span>",
"    &nbsp;&mdash;&nbsp;The secondary tissue phase occurs when organisms that have invaded capillary endothelial cells induce cellular proliferation, producing hemangioma-like nodules in the skin and mucous membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/6\">",
"     6",
"    </a>",
"    ]. Although most patients do not have a history of recent febrile illness, verruga peruana can appear two to eight weeks after the patient has apparently recovered from Oroya fever [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/3,10\">",
"     3,10",
"    </a>",
"    ]. The verruga lesions have been classified into three types: miliary, nodular (subdermic), and mular [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The miliary lesions appear as small, round, soft, pinpoint papules that cluster in crops and are confined to the papillary dermis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/2,10\">",
"     2,10",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_picture graphicRef66284 \" href=\"UTD.htm?36/55/37745\">",
"     picture 1",
"    </a>",
"    ). Untreated, these miliary lesions can then progress to the nodular phase with nontender, wart-like lesions that may become pedunculated (",
"    <a class=\"graphic graphic_picture graphicRef60673 \" href=\"UTD.htm?43/7/44159\">",
"     picture 2",
"    </a>",
"    ). Some lesions may be subcutaneous but become apparent on the skin surface as they push upward, making the overlying skin thin and purplish in color. As they evolve into larger and superficial lesions, they are classified as the mular form; these lesions are highly vascular, bulbous, tend to bleed easily, and can ulcerate (",
"    <a class=\"graphic graphic_picture graphicRef76799 \" href=\"UTD.htm?25/6/25711\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Patients may develop lesions on mucous membranes or internally, and lesions can coexist in distinct phases on an individual patient. Patients with verruga peruana often have concomitant osteoarticular pain [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/7\">",
"     7",
"    </a>",
"    ]. The lesions of verruga peruana can be seen either in growth or in regression, with the two stages sometimes occurring simultaneously in the same patient [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/10\">",
"     10",
"    </a>",
"    ]. The complete development of each nodule generally occurs over 30 to 60 days. Without antimicrobial therapy, lesions may persist for months or years. In the regressive stage, the verrugas become paler because of decreased vascularization of the nodule. As they resolve, there may be some residual hyperpigmentation, but scarring does not usually occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In endemic areas, the cutaneous lesions of bartonellosis are recognized by clinicians experienced with this uncommon disease. The distinctive lesions of verruga peruana, however, can resemble those of bacillary angiomatosis and may also need to be differentiated from yaws, pyogenic granulomas, acquired hemangiomas, and Kaposi's sarcoma. Because most of the cutaneous lesions of bartonellosis are vascular and exophytic, they can be clinically differentiated from other infections such as deep-seated mycobacterial or fungal infections that may manifest with nonspecific nodules and plaques. Biopsy of a skin lesion may be necessary to confirm the diagnosis of verruga peruana in some cases (see below).",
"   </p>",
"   <p>",
"    Oroya fever may be confused with other infectious illnesses that cause fever and systemic symptoms.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Malaria and dengue share some common clinical features and similar endemic patterns with Oroya fever. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5543?source=see_link\">",
"       \"Clinical manifestations of malaria\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18985?source=see_link\">",
"       \"Clinical presentation and diagnosis of dengue virus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Oroya fever may mimic infection with Salmonella typhi in areas of the tropics where typhoid fever is common, particularly in patients with prominent gastrointestinal complaints. In addition, S. typhi may cause secondary infectious complications in patients with Oroya fever. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42024?source=see_link\">",
"       \"Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The clinical features of Oroya fever overlap with those of leptospirosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43879?source=see_link\">",
"       \"Microbiology, epidemiology, clinical manifestations, and diagnosis of leptospirosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of Oroya fever is made by blood culture or by identifying B. bacilliformis organisms on Giemsa-stained blood smears [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/10\">",
"     10",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_picture graphicRef58621 \" href=\"UTD.htm?1/41/1682\">",
"     picture 4",
"    </a>",
"    ). Although more than 70 percent of patients with acute Oroya fever will have a positive blood culture for B. bacilliformis, there is often a delay of more than 14 days before the culture is positive [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/11\">",
"     11",
"    </a>",
"    ]. The blood culture in patients with verruga peruana is only positive in 10 to 15 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/7\">",
"     7",
"    </a>",
"    ]. Thus, the diagnosis of Bartonellosis in patients with verruga peruana is generally based on the characteristic clinical features with or without a skin biopsy specimen that shows compatible findings on a Giemsa-stained sample viewed under light microscopy. A more definitive diagnosis can be made by visualizing inclusions with light microscopy or by visualizing individual microorganisms with electron microscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The histologic findings of the verruga peruana skin lesions are a highly dense proliferation of small and large sized blood vessels, often resembling pyogenic granuloma or Kaposi's sarcoma [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/12\">",
"     12",
"    </a>",
"    ]. Neutrophils and endothelial cells predominate in the dermis; histiocytes, plasma cells, lymphocytes, and mast cells are also variably present. Hyperkeratosis, parakeratosis, and mild acanthosis are observed in the epidermis.",
"   </p>",
"   <p>",
"    Individual organisms are not usually detected in sections viewed under light microscopy, even with the use of special stains. In some cases, however, Giemsa staining of a biopsy sample will demonstrate characteristic cytoplasmic inclusions, often referred to as Rocha-Lima inclusions [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/12\">",
"     12",
"    </a>",
"    ]. In addition, electron microscopic studies reveal the B. bacilliformis organism extracellularly in the stroma. In addition, investigators have observed phagocytized B. bacilliformis within neutrophils, histiocytes, and endothelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibody tests for B. bacilliformis infection have been developed [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/14\">",
"     14",
"    </a>",
"    ], including an immunoblot test that uses sonication of whole B. bacilliformis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/15\">",
"     15",
"    </a>",
"    ], and an indirect fluorescence antibody (IFA) test [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/16\">",
"     16",
"    </a>",
"    ]. Although these tests have been useful in epidemiologic studies, their sensitivity and specificity for clinical practice have not been determined [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prompt initiation of appropriate antimicrobial therapy is essential in patients suspected of having bartonellosis (Oroya fever), since the mortality rate exceeds 40 percent if no antimicrobial therapy is given. However, there have been no randomized controlled studies to determine the optimal treatment of bartonellosis. The recommended antimicrobial therapy is based on small case series.",
"   </p>",
"   <p>",
"    In vitro susceptibility testing for Bartonella spp has been difficult because the organism is fastidious with primary isolation requiring one to four weeks of incubation on blood agar plates [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/17\">",
"     17",
"    </a>",
"    ]. Several reports, however, have provided information on in vitro antimicrobial resistance with B. bacilliformis and have characterized the mechanisms of resistance at the molecular level [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report, the investigators easily selected",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      -,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      -, and erythromycin-resistant mutants, but failed to select for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      - or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      -resistant mutants [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a separate report, investigators from France identified a natural mutation in the fluoroquinolone-resistance-determining region of the DNA gyrase and thus concluded fluoroquinolone compounds should not be used to treat any Bartonella-related disease [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another group analyzed five clinical B. bacilliformis isolates, four of which were from patients in the 1950s [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/20\">",
"       20",
"      </a>",
"      ]. All of the strains showed decreased susceptibility to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      , suggesting intrinsic fluoroquinolone resistance.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Oroya fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     Chloramphenicol",
"    </a>",
"    is the treatment of choice in endemic regions as it is effective against B. bacilliformis and also against the secondary infectious complications caused by enteric pathogens such as salmonellosis. The effectiveness of chloramphenicol is illustrated by a case series of 26 patients in Peru who developed a febrile illness later identified as Oroya fever [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/9\">",
"     9",
"    </a>",
"    ]. None of 10 patients empirically treated with chloramphenicol died compared with 14 of 16 (88 percent) patients not treated with antibiotics.",
"   </p>",
"   <p>",
"    The addition of a second antibiotic to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    was found to be more effective than chloramphenicol alone in a retrospective series of 145 symptomatic patients (68 with Oroya fever and 77 with verruga peruana) diagnosed in Peru between 1969 and 1992 [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/7\">",
"     7",
"    </a>",
"    ]. Sixty-seven of the patients with Oroya fever were treated with antibiotics; 23 with chloramphenicol plus another antibiotic (eg, penicillin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/37/37462?source=see_link\">",
"     cephalexin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/11/3253?source=see_link\">",
"     dicloxacillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    ) and 42 with chloramphenicol alone. Six patients that received chloramphenicol alone either had a poor clinical response (three patients) or relapsed after treatment with verruga peruana (three patients). The three patients that had an initial poor clinical response responded to a change in therapy to either penicillin or trimethoprim-sulfamethoxazole.",
"   </p>",
"   <p>",
"    Fluoroquinolones, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    500 mg twice daily for 10 days, have been used successfully in adults and, in the past, have been recommended as the preferred alternative to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/17\">",
"     17",
"    </a>",
"    ]. Although there has been some clinical success with fluoroquinolones, based on the in vitro resistance data discussed above, we do not recommend using a fluoroquinolone for the treatment of Oroya fever. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Treatment'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Based on available data and recommendations from an expert panel [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/17\">",
"     17",
"    </a>",
"    ], we recommend treatment of Oroya fever with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    (in adults: 500 mg oral or intravenous every 6 hours; in children: 50 to 75",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day oral or intravenous in four divided doses, maximum daily dose 2 g) plus a second antimicrobial, preferably a beta-lactam agent, both for 14 days (",
"    <a class=\"graphic graphic_table graphicRef77298 \" href=\"UTD.htm?33/59/34747\">",
"     table 1",
"    </a>",
"    ). This combination will provide effective treatment of B. bacilliformis and also cover likely pathogens that develop as concomitant secondary infection [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/7,11,17\">",
"     7,11,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The recommendation to add a beta-lactam agent is based on experience that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    alone is not reliable for treating Oroya fever [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/17\">",
"     17",
"    </a>",
"    ]. The expert panel recommendations do not provide specific guidance for a preferred beta-lactam antimicrobial. Based on available data, we recommend penicillin as the preferred beta-lactam agent. If oral therapy is used, we recommend using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/46/23269?source=see_link\">",
"     penicillin V",
"    </a>",
"    500 mg every 6 hours (20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every 6 hours for children). For intravenous therapy, we recommend",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"     penicillin G",
"    </a>",
"    at a dose of 3 million units every 4 hours (400,000",
"    <span class=\"nowrap\">",
"     units/kg",
"    </span>",
"    per day in divided doses every 4 hours for children; maximum dose 24 million",
"    <span class=\"nowrap\">",
"     units/day).",
"    </span>",
"   </p>",
"   <p>",
"    Given the in vitro resistance data with fluoroquinolones, there is no clear recommended alternative to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    for treating Oroya fever. If chloramphenicol cannot be used, we recommend using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    100 mg twice daily for 14 days. The recommendation for doxycycline is based on in vitro data and from experience treating other species of Bartonella. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Treatment'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The group of investigators who performed the in vitro resistance testing noted above have suggested that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    may be the preferred therapy for both Oroya fever and verruga peruana [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/18\">",
"     18",
"    </a>",
"    ]. Given that inadequate clinical data exist using this combination for the treatment of bartonellosis, we do not recommend using this regimen as first-line therapy at this time. Based on the in vitro data noted above and the experience with doxycycline and gentamicin in other Bartonella infections, we believe clinical trials are warranted with this regimen for the treatment of the acute and chronic phases of bartonellosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Verruga peruana",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of the eruptive cutaneous phase of bartonellosis (verruga peruana) is based on the retrospective case series from Peru described above [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/7\">",
"     7",
"    </a>",
"    ]. In this series, 55 of the patients with verruga peruana received antibiotic therapy, 46 were treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    (10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day for 10 to 14 days) and nine with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    (15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day intramuscularly for 10 days). The outcomes of treatment with rifampin were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      37 patients (80 percent); good response",
"     </li>",
"     <li>",
"      7 patients (15 percent); fair response",
"     </li>",
"     <li>",
"      2 patients (4 percent); poor response",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Outcomes with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    treatment were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      5 patients (56 percent); good response",
"     </li>",
"     <li>",
"      1 patient; fair response",
"     </li>",
"     <li>",
"      3 patients; (33 percent); poor response",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based on this series and recommendations from an expert panel, we recommend",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    (10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, maximum dose of 600 mg) as the preferred therapy for patients with verruga peruana;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    is considered the best alternative (",
"    <a class=\"graphic graphic_table graphicRef77298 \" href=\"UTD.htm?33/59/34747\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26503/abstract/17\">",
"     17",
"    </a>",
"    ]. With successful therapy, the skin lesions typically resolve within one month. Although in vitro data suggest a potential concern for resistance with rifampin monotherapy, there are inadequate clinical data to recommend using combination therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bartonellosis, or Carrion's disease, is a disease caused by Bartonella bacilliformis and transmitted by sandflies of the genus Phlebotomus. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bartonellosis is endemic to certain areas of the Andean regions of Peru, Columbia, and Ecuador, referred to as the \"verruga zone.\" (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Epidemiology'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Infection with B. bacilliformis causes a biphasic illness: an acute febrile illness known as Oroya fever and a chronic cutaneous phase known as verruga peruana. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If untreated, Oroya fever is associated with a greater than 40 percent mortality. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Acute phase (Oroya fever)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The secondary tissue phase, verruga peruana, can appear two to eight weeks after the patient has apparently recovered from Oroya fever or it can appear without an obvious prior febrile illness. The verruga lesions have been classified into three types: miliary, nodular (subdermic), and mular (",
"      <a class=\"graphic graphic_picture graphicRef66284 \" href=\"UTD.htm?36/55/37745\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef60673 \" href=\"UTD.htm?43/7/44159\">",
"       picture 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef76799 \" href=\"UTD.htm?25/6/25711\">",
"       picture 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Verruga peruana'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of Oroya fever is made by the blood culture or by a Giemsa-stained blood smear that shows the B. bacilliformis organisms. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of Bartonellosis in patients with the eruptive phase, verruga peruana, is generally made based on the characteristic clinical findings with or without a skin biopsy specimen that shows characteristic histologic findings. Blood cultures are only positive in 10 to 15 percent of patients. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prompt initiation of appropriate antimicrobial therapy is essential in patients suspected of having bartonellosis (Oroya fever), since the mortality rate exceeds 40 percent if no antimicrobial therapy is given. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend treatment of Oroya fever with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"       chloramphenicol",
"      </a>",
"      plus a beta-lactam agent (preferably penicillin) (",
"      <a class=\"graphic graphic_table graphicRef77298 \" href=\"UTD.htm?33/59/34747\">",
"       table 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Oroya fever'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend therapy for verruga peruana with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      );",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"       streptomycin",
"      </a>",
"      is considered the best alternative (",
"      <a class=\"graphic graphic_table graphicRef77298 \" href=\"UTD.htm?33/59/34747\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Verruga peruana'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/1\">",
"      Eremeeva ME, Gerns HL, Lydy SL, et al. Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species. N Engl J Med 2007; 356:2381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/2\">",
"      Ihler GM. Bartonella bacilliformis: dangerous pathogen slowly emerging from deep background. FEMS Microbiol Lett 1996; 144:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/3\">",
"      Alexander B. A review of bartonellosis in Ecuador and Colombia. Am J Trop Med Hyg 1995; 52:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/4\">",
"      Amano Y, Rumbea J, Knobloch J, et al. Bartonellosis in Ecuador: serosurvey and current status of cutaneous verrucous disease. Am J Trop Med Hyg 1997; 57:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/5\">",
"      Chamberlin J, Laughlin LW, Romero S, et al. Epidemiology of endemic Bartonella bacilliformis: a prospective cohort study in a Peruvian mountain valley community. J Infect Dis 2002; 186:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/6\">",
"      Bass JW, Vincent JM, Person DA. The expanding spectrum of Bartonella infections: II. Cat-scratch disease. Pediatr Infect Dis J 1997; 16:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/7\">",
"      Maguina C, Garcia PJ, Gotuzzo E, et al. Bartonellosis (Carri&oacute;n's disease) in the modern era. Clin Infect Dis 2001; 33:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/8\">",
"      Kosek M, Lavarello R, Gilman RH, et al. Natural history of infection with Bartonella bacilliformis in a nonendemic population. J Infect Dis 2000; 182:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/9\">",
"      Gray GC, Johnson AA, Thornton SA, et al. An epidemic of Oroya fever in the Peruvian Andes. Am J Trop Med Hyg 1990; 42:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/10\">",
"      RICKETTS WE. Clinical manifestations of Carri&oacute;n's disease. Arch Intern Med (Chic) 1949; 84:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/11\">",
"      Magui&ntilde;a C, Gotuzzo E. Bartonellosis. New and old. Infect Dis Clin North Am 2000; 14:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/12\">",
"      Arias-Stella J, Lieberman PH, Erlandson RA, Arias-Stella J Jr. Histology, immunohistochemistry, and ultrastructure of the verruga in Carrion's disease. Am J Surg Pathol 1986; 10:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/13\">",
"      Bhutto AM, Nonaka S, Hashiguchi Y, Gomez EA. Histopathological and electron microscopical features of skin lesions in a patient with bartonellosis (verruga peruana). J Dermatol 1994; 21:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/14\">",
"      Knobloch J, Solano L, Alvarez O, Delgado E. Antibodies to Bartonella bacilliformis as determined by fluorescence antibody test, indirect haemagglutination and ELISA. Trop Med Parasitol 1985; 36:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/15\">",
"      Mallqui V, Speelmon EC, Ver&aacute;stegui M, et al. Sonicated diagnostic immunoblot for bartonellosis. Clin Diagn Lab Immunol 2000; 7:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/16\">",
"      Chamberlin J, Laughlin L, Gordon S, et al. Serodiagnosis of Bartonella bacilliformis infection by indirect fluorescence antibody assay: test development and application to a population in an area of bartonellosis endemicity. J Clin Microbiol 2000; 38:4269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/17\">",
"      Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48:1921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/18\">",
"      Biswas S, Raoult D, Rolain JM. Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis. J Antimicrob Chemother 2007; 59:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26503/abstract/19\">",
"      Angelakis E, Biswas S, Taylor C, et al. Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA. J Antimicrob Chemother 2008; 61:1252.",
"     </a>",
"    </li>",
"    <li>",
"     Del Valle, LJ, Flores, L, Vargas, M, et al. Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones. Int J Infect Dis 2009; [Epub ahead of print].",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5516 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-B32189B1BC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26503=[""].join("\n");
var outline_f25_56_26503=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Acute phase (Oroya fever)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Verruga peruana",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Serology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Oroya fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Verruga peruana",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5516\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5516|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/55/37745\" title=\"picture 1\">",
"      Miliary lesions bartonellos",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/7/44159\" title=\"picture 2\">",
"      Nodular lesions bartonellos",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/6/25711\" title=\"picture 3\">",
"      Mular lesion bartonellosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/41/1682\" title=\"picture 4\">",
"      Giemsa stain bartonellosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5516|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/59/34747\" title=\"table 1\">",
"      Treatment for Bartonellosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18009?source=related_link\">",
"      AIDS-related Kaposi sarcoma: Staging and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29879?source=related_link\">",
"      Basic biology of Bartonella species",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36583?source=related_link\">",
"      Clinical features, diagnosis, and treatment of Bartonella quintana infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/26/5543?source=related_link\">",
"      Clinical manifestations of malaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18985?source=related_link\">",
"      Clinical presentation and diagnosis of dengue virus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/5/31830?source=related_link\">",
"      Endocarditis caused by Bartonella",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=related_link\">",
"      Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42024?source=related_link\">",
"      Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=related_link\">",
"      Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43879?source=related_link\">",
"      Microbiology, epidemiology, clinical manifestations, and diagnosis of leptospirosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_56_26504="ICE normal MV";
var content_f25_56_26504=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73918%7ECARD%2F82552%7ECARD%2F59077&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73918%7ECARD%2F82552%7ECARD%2F59077&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Intracardiac ultrasound examination of a normal mitral valve is shown in diastole and systole",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 202px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note that individual chordae tendinae are visible and the thin leaflets of the mitral valve.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    ICE mitral stenosis 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 180px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intracardiac ultrasound examination shows a stenotic mitral valve with some leaflet thickening and a hockey-stick appearance of the anterior mitral valve leaflet.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    ICE mitral stenosis 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 203px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intracardiac examination shows a severely deformed mitral valve with extreme thickening of valve leaflets and subvalvular apparatus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26504=[""].join("\n");
var outline_f25_56_26504=null;
var title_f25_56_26505="Morphea and lichen sclerosus";
var content_f25_56_26505=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82529%7EDERM%2F74154%7EDERM%2F58841&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82529%7EDERM%2F74154%7EDERM%2F58841&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Morphea and lichen sclerosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 260px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD0tip4I6GkTBYFiM9qJhnG0c45pgf5vk6DrXj+p9G0NmYdjwO9NzuUfShunPQ0gcFecc+npSaBLQeSVxjpTtuFUj/9VRA468gU7PHXgGpt1BjHOME59KgkdQD654p0h3nC8DtTQuQO5ByKZWwyMkKV5+b9KjDncR39anTABJPzAH61CQMlsckcik5W1QWTHyPuiCkj3NIynaOwHQVUBYklumetXI9zlS2AvAFPmuUlyoIpNykHgA/pU1vg5Y/dHQUtwiEjAC5GKbFGVUsD0p3syXZomEg24H41GSOueOlNY7F68E9KfcIEjTHrim7iTGBsHC8AUrsQAepHWo5DwT696YW+UDnOaNx2JN3B5walgYbyHJxjgVXbsO/rTrVgJBwTmmhMklYM7bV9hVTP5dKvhV2ksACO1UJHyTnvVtXEgZvkOOlQOccEnH9afkZOelRu24E54zUJjQmMEE9uKhlYEkA0ruAcdc8VDuHOenXNUnoLUibKqw54p6YAGR83ahACSzZIPGKe4BXgfhUPXQrluQyk7vX69zTHfGCOo708DOCevamqvr1JzU6BYTYflyevJqGVCQSMHHNWgDleMVGyjbnv2NFtQXkZzJwQvf3pgUg5PHsafMGEhCnpzQ2QCRnnrWkrcpSbI48lwxzmp3G4Yz361CDkccAdaN3IFRbQbQ0jDZ6tUSqS5LE4p8r5ODnP9aYxPIJzxStqAuckEDkH8qr37bYwTnbipkG1sHgA5qtfMC2ByQK0i1uZNe8ZyjdKxPTPGa04oy0WcgZ/lWQ0xR0A6k1rQTbrUZAyP5Un3Zs2xdhYjkjHrTJsHYO5z1706R8KjAcdPrTGXcFPYHil5Iz82Nl54wSOlOQkRsASKj38kYyRTJ5Ci9Du6Y/wp6bg10AYGNxGehobBGSD1/KqQlLSKSMAcZq2jZX0pLfUzae4xshwc/dHH+FQzYZ97c4PAqZ92WwM1AY28nB6nt6VVk0Su5XlfLHJwvtUEBIjPGMNxVhkGSOn1plsB5O2QEEHg4prQGtCCVSWxjPGDUEiZyWOc8irEnBI5GP51FLu3Z4HOcVfU532PoVwpXIqKNMSHsB0pG4YhTgGlZvTgiuax2A5B49RVTkFu3FTtjHTBNQSHOSRge9U9WNaCq3Jx0xTHclR6d6FG1GJHOKVsbcdc01sMIMlvanbgr49aYGKDkHnrSSMfNJHUj9alvuD3FUKbjGcY6E1FK3LFeuf0oZcsCTgEZIPaiZD8pAyrAisegWuRSOGCjgilWQlQCcDv9agmU7lHTpTtrJIoxnPJqlLqNaFqR8xHByafbuQwxz2P1pjKN4APy1IqhHOe9CWonsSuBIhHAP9ajnJCgEHcKWVwCdueopkkwYgjk/1q7shKzGj5lIOelIflAwetOAAUNnJzSxruA9aaLuiFxkHsO1LGeVHNN6khjwBT1wGGeB7U07j6EsrEdCKz3PJ7jrV6chQcdhWbIQ27bxgVaFFaEgYFW77ajkGYxt45qOLO3r17VIGGRkkAdKkGrEB4k9hTJU3E4NPkOHJznPAFNyV5Yd8DFOOodhsfB9Qe1KzHa5z0P51DI/OGyM88fpS7vn69fWlIuwofMnTGenpSbiW49eM0u5ckDv19qSdlGCvGOmKl7E9RTnevXHSmsMhwB16U0PkcnniovMO85Iz2o30C1iKQbTnHzVDM+EBxz6UyacNKRk4JpGcyIcjPH51S2L5dbiJICh5570zkSBgeBUMasmdx5PP4USPt6n2peQ7diQuBJ8x4Hf1qNn+Yc5HpULyYyM9KiRypxnpSSvsCRZlkAXHrxVG4lOSeoHBqSUkgbj1HFVp8bQADu9apOwJXKzSqUCnG4GtK0b5Ardz+lZBO+UYADCtC1IDDIO7qaqQSjZFqQEPhunPSmrIQoBwDzSbi4YjqDUQyQFPfvWaepD1HxkByf51G7l365FJghiOoxUkK7kbPBpqV9CHsU4YmdsdBn8KvooViDzgflTljyu4YBAoZwpJ9e/tUpakXuBAKqQe/WoZFBLKMgYyPenxMMMe3JqGV9oQY57/AErVK5mkyCdf0P5mooMM5JzTZZMKQ3GTwaW134AHXJ/KmBFIVcjAwScc1VuOGBwc4q3IjRkFlyGPY9KqXjbGKnnt+FXqtDNWbPfS3BB7UjsMDtUfK5xgk0x87QO/XNYPyOpEit271G+cYxnB6UDufQd6jy2M9CTQMfj246UwqQQecZ5zUm8KSuMnHWnFNxVWbA+nUUnpoUmR3RwMoeP5VHBkDc/PPcdacAHQpgAgnB9RTokBZV9uayk2n5iexI0e4hgd2RgE+npUD7QoxkL6VaicqnlnBXioJlBkfCkYOMelVZpArkRTcBznFPVM8n8DTfuKSOnQULNhh9KSshFpbcbQRyvY1UnciUAc54qyJv3ZDcY6fSs2aXa2706UNqI0rsmZznHX1HpUay8lj0quXZnJA6GpSAyZx9aQ2rbkgLABt2Bjv61PA4ZV7MPvGqDPjCHOBTY5CpYnIBFCfLqLluXWOZWxSM3Xb0FVoJwXYdSfX0pjufNK5OK0i0OxZLs3yH9O9V7nj8xTZJCXB54ovTmLrlsgkVrYa7ERb5uvTim+bwfUVGgA+Y9DSs6qQSB6VOi3C1wdj5g460h+6xZsCoZH3NjGRTygKYY85xTj5DtYiYZbOcnrmnx927A96cIlwuDxzTGXardgamSV7lbqwwOFbJ6E8/4UTyKU9AOarytuI29OlRyNyCOmefpSXYOUlkkITI4OM0wsWGTncBmkJ3qM9+T703JAx+GardWFYruoKkZw3UU45UKM9RmmyHaD69jVfczMMHipWpe4SNl06evXt6VHPmQryOtP8vAJJ5HamnsTzx+lUn3HYbtAc8d81HIMk44yetSD584B4pm3PB6rU83QVxrNyoxkiq8p6HA5BJqxIPn46jNVpxgDPUnGKSe6Yo2KJYCcYGM1dh6lj0qkVH2gc+2a1oEABAxkgU532CpKxJACY2JAAJ60xlIXIOQPWrKIohwcE5/KorhtsbY6Y60rWRjzXehWjIIYN6UsJJZhyeOabCjFuc4PH0qYRlCMnHbPrTs1sDtdocX+XC8AUx1O0bj838/WpZUIhdeM9RTAjMgHGO59KqOjSZm3poRrlMtkYyaglPfkjrVmVSEQtg5bmoiPvAgYIIFOXkTfUpJGZE+XjjgY61N5LRydT0x9M1NajapHBI/QUydt6SEHnjnvWkbMUk9yG6tJ44Y34KnOfUVkX/8AAQOcd66Cd3uLYrGD52OvbANY+oKDsXjjNaN3RhF+8e3eb8/XtSeZkYzz61Aq7SQeTUqp3GBxXGjsdkSN8pIJ4wKQHop61E2XIHTFO68E5NOTuNDzywxz65p0jFyAf+AY9agD/Oeflp7S/KGXqvU1Ld7tlEiYMZGeSeQamhQsy7TnHT1qKBwY8sBuGcH1FTQFUZWAOOvNK2tyW+hLEm/Ixz0pGVCjKBg9z61NG8YZw31HtVackrweelUyb6lRlbHXg8VQu5DGQScAd6vzSMExtyB0NY+oM5X1IPpWMrJFxV3qON8QpDH8KRZPNU+vaqUERcr5nUHkVpxxxryoIpLVXuatWGW+cYHbmp1K4IFRcxk47+lIufmFNaES1EkI+bnnIxQzrs547VE+CWJ7dqicOzDYpOapJWKsE8jBjs7jrTUmJA3Z+Xr9amjtnjwJBznrSSxgDI5JPNVyO1xXXQaX3KpXJxzTbpzsXOc9CaQyhepUZHSpWcOqg4KjkitIySQ1oQ5Pk4A68/SoGDMxI6CrGSVwowCeKYZFxxgbfah6i2ZEuS/HPH51K2RHnBJqDdyccGkuZ3VcDPzfpVRLSuWtx2DIOepFMA8xiSCR2H9agtZ90LlmJI9fWpoH82IHB3VEmrjaaRFcxBSvl9ACKixEEJcYJFTz7gQMjGKidSclgNtNSTMyqMRxjn5e/wBKZLnbnJwafLGSzL780yQYUqTkcGlFFJjHI2jnkcmowAJBnuc/SnLjCAcknJzUbt86rsP+FKTsVsDN+9Ud2PWknUJwO/WnyIVXeeNvTNRNGzklsmo5ncm/UY3MmVGA3alWLLHnrUqQsMOenYUI+H2kcj+dN3T12Jb7Eezg4HOcVUulAxk9O1aixHeeuSelU72DEeSMY5/GhN7ijLUxgQ0q4BznjitOLgjPHvVGBWMmAozmtXy1JwCSKqSvK5dVpWHoG8rKjA7VNHb+cgyOO4pscpICcADkA1etOOcA/KTiqdtDnYz7EFG4DGRgVSePEnHQHjNa0pLR9eg4+tU1XLFW5wM0iLszp3bnggZI/wDr1D53krtc9cYNaNxAGU4Ge/Ws69gJk2rjAIOad0yotPQbLP8AL82Dz0qJ2bapxwDimXSBMMckDtU6ASQEDnIz+VVd3sJ2I48CUgNg5/OnfJDMJP4/7p6GhYwDkfeKg1C4CzR7gX28la0WgpMtTzMbQunXYQP9msiUb4gMZKA859K2GkiVZiD90HaO5qlJtktn24U9TxWr97Q59VqeotMwY9M+tL5pIGTjAqrLIByOneovOyo6+tcCn1R32NFWIKv3AzStJ1cHrVKG4Una3Uins642joad+pNtSckhC2e/SrMCgovP1AqrC4DKp6AVoIU3Axjn0qY6jemgkSBVZevJ4qZGbbg5GOM0nmqvOzbk4x6UPdNgBQFA7irsRqTRI4xt5XrzSsnduDjNQLJIf4jg9TUqkBMEkn1oa1BkcoDoNxxisy4gXepBznitOZgBtxk9qpPtMgBPepa7lxdiuLQA5BpyQEqSD3xVl2Crjb74pokySB2HSoUV1C7epCts2R6A0/yAOR1NTNIWXgYIFRwyZkK9/WtEuhLbsEdnHuLMeB1FPHlRYKjPamSOykkN1JFVipIxuNUl2Hr1Jri4LHgAYGcnrVGZN/Izg8mrHlkrggkmoHjkSLGfb60PWyHa2xSiiB3MwBB/ShBGJWQk8dh3qS2idhIMYXr9agkt2IbG7I6kmsrWXMi+thZR5LORIAG7VVaYMQqjOByaHgJkR2JIxj61HcZjDbFyTjmqTfQaRLEcSduTzUlwUdQWcZIyPaoYwyDac5POKjA2EMCSR2IreMerGnqNgj8rcu76VZtpSGKlu/WoJZQVBJHHFPYIkK8/M3J55qHbmLk7oteYspOOq1C822Jxxk81H5irEGUHmq5k3KxNQY8upEzEyBmOc96HcB8evempgDJzkZpfmfA2445P40baDW4bfmDk/T3qaOMsRnGR196S3QtIofkBs1otGNjbgBzx9KFqE5WKkkXynIypqNoDtyvAqzPzGoB6H86bkiIjHU0JpydyNbCJGoiG4Hg8UxIF8wHHOakjYELgHgc1CZQHOcHPBqlqtSbMlXDSE9Np61SvgvkyHHOKsNGTC2zjbVO5LPFwMdsUm0thqOpj2+VkdSQfm6g1sxqCoHQnr+VZkSAHav3gSau7mzHwVZutJvqjSqrj8A4BHPrUkEwjIU8gdvWowxzk9ADUEj4kxjPUCiUr6maV9DaikXbkHIwcc9agkb720cHvVRZ9sBY8YPakN4rrjI4GT700Q4dS00gUkYG3GBVa46ZPAxUcN0C4DHqadf3MYRlGM7cU4u+hm42MqeUPKqH7vP41Zs2w4AweCBVAnc2cgEDAqa1OSvPUcj3pq/UtotlAVXJGSdvFQI2x2ymSwK59qsfMzAnOFH51WZzBMh6jvmto6kWvoWXhE0sJEeNsJV8dWPUVVjdUhbIKkn5h3Aqy94ftp2giAADb3wR1+tVCweSUrgqg/iHJFXojJq530ijP3u3SqUsgi3HnHUk0SSMQNp5IqlcsypmQ8ntXnLsd1tSzHdqScKfY+tXYZwSAeK5bzHZmZHYEH9K0La+BCeYd3PXvWvKJ6HTQFSCDn2q7GSOBnIHWsGGeQkBeTWtC7qPmPJ6ihLWwLUvRpK2ChyV5we9OUzFS+Bj6VDbJLvBibgc1YWKcgZXAHXNapaBfWwRk5AJ9jVnGBkEHPSojbgyM0j8n+FatoqCPgbeOAaXKJ9yn5LSlm6DPFRm3Bz/CB3NaCgDnIzn9agypbG78aHFBcpSxH5QQd3f6VEqbXOTljxV+YeZjYOfSqqRM04HvxWbjYE+gqoQhz+AqJECurYIzyR61d2EMVZtpXpgU9ERdxeJpAB0BxVpC5imYJDKeACeee1QhpBLsC5IPpV5VUEGRwue/X8KgZlzlA27vQ0Cd2O2SMp+XaOmaSe3AUA9u9XhkovHfvSXds5w5YFByQKdrakp3M+NUWI56HBrLykkzndwT6VvSxosJyQAehrIhTYzocYPOfek7vRFw6ldolfdgEgdMCs54ih/eKclga2fNMbhWHJP5iq90UmnK84Xniko63RSbuZoOGZ279KjJw2cDIbOavrbp5gOTiqkgUSybl446VtctIgZEkYggDccYpsyBEUnliMYqzCi+cXdT93A+tNmiKyKx6Abiaxkyk9bFQtlG+XhR6dDSeWFWPBwxPIqZF3qfnIDnJHTFIRwwBBI4H0pNa6CdypM4j3MEyoOMU5WOM9qdMp8sooBwRn39KYQyxAZ4zwaaRNtS3CBhSTkqf1q3Kf3eBwxGapQEFfYDFXQpd43GABxg96SbRL3uyrOSgwec0Z3YA6AZxS3beW+7HzZxzUcTbCpPc4FQ3roVa6uOCsFwmN2f0qnLG7ysp4xzWmVI5PXrVSUfOeeWHP4VSWhK3EikIQhh1yCKSRd1ueB14p4xlSFPXJ96e2EXYRz0qo9xMwTH5ZJzyTwK0IV83aw+6DimGFXYyc4zjFTSusSLsGCecUobO45yvoLdwFU9DjB9KpSBcqQfm4qWaZ2Rlf681T38853Z7+lNa6ExTS1JZD5kByPas1l2NgdMY+tWzIApB/i6GqQy5bf1U4FVbsUhofbkHqT19KbNM+CGzk9+9PkVsL65GKZMQQQBnPSk0DSIVYq4weMfhU1tuWVBuG01BkKoB7cU+LO0KeCp4NO3UzltoaoZyo2tzmo5yHOMgKF4z3qFHIBHqOamKh4ScEH1qk9TNKw144jHIXkKvtHNV9mXZ93zHGSOmKmKYjRmUkYxx0NNKx/3Npx/9atU7kSWuh1Qk8tcj5mx8qZ5NNjsbmcEy4XPPrWtplgY8PMAZD+ntWzFboSOgJrmtbRnRzanPQaTFFGQU+YjqazdQsArFkGMV2y2wdvx4rK1eAJnIOPai7sUnqUNDibcNx3BUzmugjX5Sx7iqOkqBaqwHLc1phCcYByBximnqNLW5csoFWMS+h55xxS3Icxb42LcdBTorY/YWJb5icirFviBGSXCsVA6dq2S01Jbs7lOCKV5ge5q8YWCAHGCefpVhJV3xtsVUOQD7VBcElGAP4Z6UNCvdleMKADyWJNNddpwqqOKieOR5MRnAUU+QH5WwSOeaxV7hYjjRgx3v16YqBI3S63s3A7VKqEuPMJXA5PemXj4YKufqe1S0Nb6BHKXPThjiryoXU7TjttJ60yGArDmIj3zSR4UAhssPTrWsY6GUnqLHCgdd3X09TSiGMSZUfNxz61RnuP3gEZ2up4qdXb7OCT3xkcVTRbiyczRs+0ckHHXvTjMdxVugNULSE+ezHkEg1NIfKBPJ54qUrhy22Ib6bM4iAxHjJqlqEogl3EYBGMU6+kO58HK4GPaqkspkiEco56jjrUNdi4xBiJtkitkAcVQjcC5bfnPXFTtiOLG7APcdjVeSP8AeA7gSwz9KXmaRWo9JTIzKPlGcE1BNMvntn7o6Z70kEZB+XIUsc1Xvo8ShlOV7itFsbKKuSSswMeOnWnzYmgLD5Tnpmog58iNNqly2Qc9B6YqcjJ6ZJG2siZoq+WUj3AH12+9SRAbSQMEfw00EvAecMP1oUMVK8HvTTtqKWo11UMSoxk96rSoSDhunWrbKSAxPQ5qMpiPdxnJxVxRnchilKLJgYxx+FWreb50Gck9DVFR8pP5g07GyYfMOnFTLXcfLdF+9TdMD6nH0qKOE4BP8JOPaiS4CqpJBwefenWsm9HJ6nmodr3ZKTtcttF8iknnH6VUkjV3+UdMjBqykwJTHNVrpxE/3QcnJ+laqyM1caTsXIxgcZqG7bzYlCnjjkVBPcKMDd9arxXJWIr/ABE8UuZdC1F7ss7/ANyV24OaaxBbLAH0pCw6sff8arXDMZDsyFz1qOawctx8siyH5uAOM1WlA2qVXHH5VKsfBB6tTxGvlEnP+FQryYbFCZWYMQOOxNRAYA3enOOtaiqBDggEgZ/Gs6U/v2wOMc1Tb3Gnd2EnUMi4wtMEOFU46GpSCwxjAx+QqUrlQvf2rTcGVHjA54FMY7V3AfSp2BxsIHpTZYR5bfgKVrmbREufLH970q8G/cquAeMEZqovyDIwRnFOZ9pAJPXJNWvd3M5eRNhljTPIXPFMkcyAbxjsB6CnKzspwepP40+UgqizgBiOCP61cWmiGd3HO0ZAcED1qYXqAA7sc9auXFuCTkc1WlsI2U5GCeOnSufVHSkmCaokLAMwOe+az9V1EXChIxkvwKkk0EuSQ5APOau2Okx28m9/mZemaHLuNJE1lCYoo1xkgDNa1vFkbcckZqKPGRgZI61PakiUbjgH9a0hq7gyeOJtnJ+98uB/OpXjTzR3BOGNISE2OwKkHAPpTRKXm3FQTkewrRmZa8tcEDlVPAqtMm1MqMmpn3gux6NzT0KsMHjI6elS3qK/Up6eu9HkkGORj3p0jImC2ME4xUt2DGjiLoBwaw5WlkZRkls1LaWhSXM7mnJtYngZHSq/k+a+XYZ9u1IS4j2nqeRTXVk2847k1S1YloXjEdwXdwB1pPJjjRs8k4PFV0nLSADK9QSO9TnKA564zVIze5nagkcbblCrxxVeO6UxbMHnnFR6wQ6qq569u1UlV3AYk8Dk+lZSk7nRBXjqblmxduDUOoSGIuByR0pLYeV/F8o5BqHUGLck49RVyWmhK+Iz7afzM7xx3FPvRuUBfrn0qAIEmbHRjn8KlnIXIXPIrNLQ0e5WB3xNGSASc81TUbWcS546EdqvSIAwZT07mqz/ADsXXIHf3p2skUixb/dHPJXBJ9ahuI/3j8AqRupY+MnacAZomcbhuPBGBim9dR3sylDGJJOeic1PdkIVJzg9/SiBGEhIxwOR6+lE3zRhZVIIyARWbfQG7sq4Knr8hOc0xHJBGRhh1qSR/k8o4B7dqaoUcbeQefehaDv1Jv4No6+/YVCwOxlxyTVlIyRuPIA6+tRbiCRjNaWMyqIwqEDn3qFy2fp/KrTYCn+EDkj3qJxlVKjAxUOTvoXErSNmMsR6E/4VZgkKoAgIeoIQS3HTpVmMbWDZ6dc96yn2HLYntnILhgAw6VDcqZxnnr+dPtyfMbcfv84FNG7Zx6ZP/wBaley12MmtbooXFs0eB1OOaSNBtXAzk5q025yC3bHWmAbmHtjn3q3azaHdsbdx7RlTuwOgqCRv9HK4ycZ57CrhG6Vyw4JxTLiAqF9CpzSa1dwT7lESM5Vfx47GpZAygD1OSPWnmNICpH8OOPSorlzIzlSMYzkmn3F6BK5RsKR04qnt/ec9c81IDu5IPByaSPh2diSc+nWna6KSsNwVkI9RViJR1GMjjBppwcEfWpoyGU9qbW0SZFe5jxMrAe3FNZcgqcc8jNWZBvkDKePSmSgcGr20RlcobMFhzgnpTZzgjAzzVqRcgmoGTehUnnkj2phJX1EjfbsBJGe/pTrgq3lk5YMOo6iqmXLbc8fyNSFz5I2MMqSMH+dVG+xk9D2jPzOxUAH1HSo2ZN5BI/8Ar0tzgMFBAB7VAUVmGT171i09jpSLBlXAXOAP1pm7LgAnJqCdAI93TuafbNl045IzzSS5nqGy0LkQY4Ug5P6VaiiRl25yQefao4ArEeY2c8BR1q5AgYkKgBH6e5raKsrIi5LANzDHzKem4dMCniNfKxGM5GSaREYNw20ZqzEqhTkjC9Qat7GcmVJHLKpZeAMfWoELiRgxAGO3NXrlQFUDBBqGQoqPgdV4+uah6gnYaw3Rbn5B6j2qijRDAxgnP1qzcNhBwWPA4ps4QIrDA4/WnYdyFApUErkE8fSq1443EKec5AqZ+gKnt0qFAFKjGfc0NW2GkJbY3DI4/rVtzksr5wO1RR/Ic8E092J3fT86d0Q9zLuFAmYFSyjgVDDbMXz90H7xq9Mo+XOSe+KFwobnAfnntWfLdmyehUvJMYXvnrVadwQx54xU7N5nmHJyPyqqWUlTnHOCKV2ykV1BWRe5zT7lSF71IEG4AdqdMrEHoRVWKuUCeg59KIF3ELjuRUyIdoIHSlj+Qg8e9K66jb6IkkQbPu4I61RnQGMEHHPT2rTwGjwByelVfLHlsDjO7I9qPISZAXUOuOoFV5mZ32j+Hv71Yni2rzzzgGmxoPnY5BHHPUVEotDVtyg6ZlUkVMyY3HIOTzRIhzjO3JyCKZhiSTkD0ojoUOjZiCpHJphBALGpQTsC46VDKdqseqgHNVbS7Je4xwMZJyCDyaqvI2MZyF6EU9izIyk4Gc5pC3OMDB6isuZrVlLQiQmN+FGPvCrCOWYbhyewqJOZNvtUhBWZeMe1Z6k3sSLwcjqDwfSkjO+RQehJPFK5AQgHnH61FGdoLdeuacXpqJFieEZAHr0FRCAoc9Mnil8xjGX5wG/KnxN5qBcYbqKqO5OozYcNu65z9ajuH3ZPYjp6U+RwEl3dQMVTDhgR/d4Jo32BK5HM273OOlVJDtww5OeauvGQ5buO3tVWbDFwBge1UrMuJGudufbH0pSvzA9CBT2jaONQOpPX8Kcq7cdwR/kVpFWKvcAAcKPx9qdtxjHSnqm0lux/Onhc4J4I/Wn8TMpMhH3+n0AokXKg9BUhUbgw78UyRT78Hmlr1IW5XYfJn3prKpwB3FTun5GoSuDjFNO2gMoeUVLMxOB3qIgoHPGCOKvygNx2xzVGUbX29s4zWuy0MHc9oucPNgcmgLwBt561IQqnK89RTJNo24P3v0rFdzov0GXEY2ZY9fSooflmV2HHUippSucscdOKahBReByc/hQ1cpaI1UwEAB4JzwOatwybQSQEHTk1ivIfl5YAdh1IqwZAZF/jDYHHatEyOU1/MRwABhe7H1qFLgF3jY4I469ajVkIw7fMOMCmlDNMGgCgDqxP60NkW1L21Tu67+lJOqtnPT9c1DapI4bLBAM4JPWllgDcvIzAHoDSbJtqVbt3Eg2MFxxioXOwZbnPSpGiVELuM/N69RSkmYk7cAdDUXaepdiBtiqTMSB2xVZplaU7Dxjipb5T5RAGSe59aoxWpRyWfjFS5a2RokrXZchc+Z82WI7VZUnEhUDrnn0qGIpFF85+b1p8kypGM5JPANVGVtDNrUilYEbSPm7c1RZ+CpIB7e9W5pPmK5wx56VUkA27hg96Tdnc1iiDBU9TycGklhIXdimyM/mFh0z09alaUyRgbaUdS2mtSBe/qo61P95Cc8dKhRTuLHpVpEAX1p3fUmRUIwMDNQzjOAOD3NXGTHI7ZNRygc/L15FPdEqVmMiVlhHPP8qa4+fmp4/u+2aG4Ymhq7BPUpMuSQenWkkBKn0PU1Mwy/J7cUD7nPfrRuXcoKh3H5c9fwoWPLjIPvVvADEE9P50gAyQOvY+9PoO7KkybNuBwTTZIg0R9O1WpcEYPFVycEgn5elFxO5QlQ8Y7jB9qYsQ6kckd66eLw49zZW919vsoEnUuqy+ZuwGK5O1COqnvSv4TlZTt1bTOOefO/8AjdRKnJ6oj20dmzkUyJD37VbQKSeTnoK6D/hEXMeRqum9eT++/wDjdKvhKVlJGrabwMnHndM/9c6zVKaJdWD2Zzfk7lOOcc5qFQS46e+K6qLwtMpOzV9LYEdD53/xuoj4Y2MzNrGmZPHAn/8AjdU6Ta0Eq0epgtGQdpPy9aWIhZQx5Gea3z4bY4VdZ0zd2yJ//jdRN4ejjIL6zpox6LP/APG6OWS6C9rHuc7OvzE888fjUKrgZ4B711Fx4fRyHTWdNCg85Wf/AONVXPhuPtrembs/3Z8Y/wC/VN09RqqjAnTcG2524yDVL7zhT3GeK6ubQokAxrmmDb/s3H/xqqo0C3jlBbXdLB6/cuP/AI1VcnQqNWKMhuMAg4HpSBAW4HU4+lbLaVZF+Nf03rn/AFdz/wDGqP7Msk5fX9M9sJc//Gq0SD2sF1MrYuOR0p20bQfwq/LDpMRXzfEWmj6Q3J/9o1Gq6QV2r4j07d0/1N1z/wCQaLO5DqL+kUHXBb0o29D1HerrLpCgbvEen5B6iC6P/tGh20WNcSeJNNH/AGxuv/jNLkZPOjNdeQcdc1XZc4b061oSTaDtyfE+mjH/AEwu/wD4xVZrzw6UYDxTpuO+ba8H/tCmoSegc6/pFSRfnbFQzwjGBjK81b+2+GwwP/CVaYP+3a86/wDfipbyC1k0qG/03UrW/tpZpIPMgSVMOgQsCJEU9JF5GR1q4waRnKaueonG0sO3SoXAKlj0PSpDEQTg5DdielA6BPQ1nFI6kuqIPLMmWbpRbD5vmHbAqyqgKfY8U50DBcAAZ6U9geuhAEbpg9Pzp53qhfuMZFSuMZToPUUix5JEhJGetSCCDc4wc4PIP/16GdlJI+mQetSElpPLRSEA6eg9TUkQVspEuVU/ePequK5aLoYxuAYsM5zTJHCqu2Pjp1pBhGJXkn8hQyFyd5CjsBQ9SFuR7i4wVCHHJPODTgYy+GkZmxjGOKYDliMY29T71MEIHBGOhNZtiZXmMQcDaD6H3pAMxnKDJOcntSyxbjnGG96aiMAA3I6Z9qzT1H5EDlnJzjaO1Nk5HD715qaSFhG4yMZwKiVcRliMN0/GqS0sV0uU/mM4XnacgZ7UoRgCex4FTStvcbT+PpSuQ4AHGeaGikyjKhD8c8U5EG7jrjnFWXXAHHGOtMwqHNXa2hpchI+9nB5zxUoUhRzmkj+eQkjoaevKuOu08UlsJkeBt57VHMp8pWx07VK2CoHemtyg/KnFXIaIwdqfTJqIfNyeOORTsEEH8KVwB93t1obBWRE4yzMRg9qgOScHp2qcg4OelMKnnjpxRsVcbt70GPBB7HsKkZeArfpSAZfGPbrRbQCBxuIz0x1qHZ3bv0xV11zGDgDFQOoTaAOB0p6Im50dvuGjaPg8i2bP/f6Wk8s7TyeR09qlgXdpGkPuwfsz59P9dJTS64I25HOfp2q5HJrd27v8xsQCTElSBjGPepNiMWUsSxHT+dVTI3zPuwuQPenLIWZcnA79vwqAsCgYypwOR7VTbGSDwR3NTPnHHIzjryT6CqNzKqP1PTJ96ktIbdMYyNmRzkH2qKR8Jljn1ouJd4GMDv16CqbSjywWYDvtpNDJmlLhQM4HH1qKYvtbB56ZqAztgYxg+npVWe5kYZU9eSR2oXdisSSSkyc5PHBNVp5sAEkZ9KYzF1G8ckDnPaqV5cBY8beTgnApbFpXJZ5cMCMHiq00jSDoOnSonf5VJ5YioriVkCheCeKdyWrEF3CCQ0npnBNQJMmMNhT6AUy6d5T156e1VFVVbBO+Tpx0FW3dDUdNSzIHbleAelVLqFG4kfn2q4+wLktgYHWs+chn3KMgjA96uCdw1Kc0QQFhgnpg1lT7mGNtaV67gYJ5x0B+77VnOpDYDtkcnit4rqJ7amfOCCSOg6mvSPBz7/hzaE9P7VvP/RNpXnF6GKkYIPb0r0bwbG0fw2tA4wx1W8x/35tKqfwsx3kl/Wx7iPmlcj0qAKPnIHPWpYg+w4GCeOabyoHf1rlbO1AAACenrTkbC7iOp4HpTtuFUHrTGT942KIsGQs/OBzjvT45QCT1yMYpjKQjHaKYq4H+9Tb0Hcu/aCEAVf3pGHb1qxbkEcqWc/wrVBVL4xj0I9avRSyIxCFQcAkntSIa0JZmyeAEGMcdqaVJQEnI9agvJV83C7myOp9aeZN7YGFVRjj6UPuTaw1V2yls9D09eKkQZG0Dnjrxmoi53e/HJqYlB3IK96hq+gmxzfeOeCOarPMER3Ayq8Hj8qfcODkHoRwarcbXBPBbp61FtLIaXcC7FB6NVe7YNGWU4fHI96lBO1SRkc1VRMJ8/XpzTNIoIwCwZMhT0pckOR70sZ2qF9O9OZcsCSBkc1SSKGSA71U9hTZEBYfSpkUl1JGSelIY+/403qK+pDEMM2TzTlTr+dOCneuBjj86eMZ55FK1gbKzjtjv19ajcbkJzgg1PKAMCkKYLAjrxQmgKrfeUdBnOKVslm7DNO2ZIJ6nildckDHyjrRuNkXO7FO2hT0yD/OhhluKe3KkDg013IbIXXI+tMIOFIFWODHjvTehXPBPpR1C5FndxntVa4Q7PlPfNW0XDZGM+9QOeGz0H6U2+ojeDFdD0eIICWt359P30mf6UzduBXZx0BzjNQ30hFho2CQRbMR2H+ulqnHOz+ZuJGOQff2qpWuc+uvr+pc3gRM4jZ+cjtjtSmYJEy4yMb+lUzcMxRVcYPB4xUF3Mfm3MeeMDjihtWugjG7sH2o4bzVClcnPrnpVWZ1RE3btzHuOlQzTlnwB0Gfr71XLllVmOXyQfas7o6OXqWZG3seflHQA5yfSqM2HmfBwF4zjjiojNgSlgQgPykdarwl2I3ZxwDz3NVuZNalsLmM5IOfm/CoJtyp8vO/samyfMAbopHygcE1XlOWbeCc+nrTcUJNleYZBydqjn/61U5nVsjHsDVq4GIyT87k4IPr6Vm3QPlgb8bz+lRylXGzyA4w2CfQc1RlnDbhkjbUzZG9udvIB9qoFGd8opz1Iz+po5SkNMj8k9D61DHIOCueTzUkqujliDkevY+tVywkdVCsoA6nv9auKVtR7k0rCUgfdVSB1zzUd5II48R4GxcnI6n2qLBwmHCMevt/jSxxoS+8SSLgjMgwwPpnt68VvTSImuXYyppJGZiAq8jndwKhfc2Cchc/e7n2q/dwRtMFiQxQquMAZLHuc1FcRx28o8sFyg4UHhM9z71b30J16mVLKzp+8CrtbaiY5A7mvSvC6lfh3ZZ6/2neEf9+rSvPniZpDIo5zjkdPwr0nw3GU8B2a8knVLwknr/qrWiesGZ7SX9dD2hk+VBz700x88YqUDJPc5pJQYyOODXIzpI3AHHU5qIofNG0kE8VZPTJ9KYy4O4kcULzG2RuoDYPTFVWXLxqe3p61cYA7iO3QVDKp85W6Y5qkOIW6OrOQRhT+QqSTJGQMKT065pFiImXBwrfrmn3CgAAEkYwB2zUy0C5A5MgUk9DxUrQlWzkgt1pkaEoSMAp/WpwCxAY9B3qbg2RONoGRyDnPWkizNIYt2Mg/MemaRZQQgxlTyR7d6ICAxxgD3qXqJodJuEiqMEYwCfSoWO1c4yCPxqxMTlTgcYP/ANaoQgD7lzt5/LNLrZCjtqMjJIDAZT3qKb5mbGMH+dWXATI5qELu3D04q4ouPcih+YkdGPSp2QsV9cdMdKckYXb6EdRTz0De9N7WBsgVwJSv8SnIpw5yzd6XAyWx1NIeox25xQSQSHbjIpjMfmUZODTjl2A96UphmOelJO7LVkMCsWO4cHpmnkZQHHNBIMeehzTicHt0oBsr4wenFOYfLgDvzTpEyc84PWm5xEMcnvTXkSyu4O3d/KgAn3zT5AfamjOTRpYQgICc+nNNfHApMkKAecfrTgpJ45HWmJ3GhcDmonTkjAw1TklMZwcetRkjIwPzptdx+Zc1MINO0lWJz9lbH/f6Ws2MbYyBls8g5q5rjbbTR+cf6K3/AKOlrNRt0gOc4Has57kQ2+/8xC7LzjDAc+lBYNF83OTTbjIJJGMcHPrVSSXhR8yjt6UrlJaliYqwwDg45IqjK4X5QML3NLJODIFUHaBjnuagl+aMFzx0C96S1HJ2K12+YXVeOBgetLEVwgfOcc47H/CiWNdigqc/3qSKN3fccZA4H0qlfm1JbSRYxuT7zBe1EhOUKBc9T7U3aQibmPGcj1qKZyMjnjk+9W2Y3I7r5UVQP7xIx0B6n8elZFwuQ7kYTIBJ6t7D/CtR1bB35GfeoPLImPT5QQvoPWouikZjAk7GAROu09FA9agd1ZsLhI+pJ6mrt2pXCoMqDnHofX3rNuId+FZCADnPcn6073LST3EeAs4cKWVvmAz0+tVpY3+cMdx4LbR90elaO7YoVyQz9eP0FQXiERRBcEAk/KeCc9PcitIq+o0yK1iCnzGUeWq5IPUHsPrTY5Ht7qOUyxyur5PmLlfpj0qW2inlZHdw4yd0hHAOOppm2VU80oGYZ2Aj5cj+In0HNbCauypeR/ZpdsmHlLHG04VQe49eOlZt9CsMjomfmw5JPYjrVwxfaFZxukjb/loT95vb0qqYpS/lPtyOZHI6UJdxWt1K8StsWQEdeM16D4WYv4CtSfm/4ml5z6/urXmvPLxlJ8tDgKMYH+etei+FojB8PLMMD82pXbD/AL9WtE5aNIhrVM9pj4dx/nNLMvygY4oUFeV7nNOY5XB+tczNiIj5SBycVEvzqPXuKnb5cccYyaaigAn1JzVR1FIjH3eQc54pJFPbOMc1JGPlDEcDtTlGWYdDxTehS0IcszxqeCvSny/wlu3GKG5fHemXB80KSegzTvpqDQsbBmKjjIxj0NPVQ3DNkY6/jVcL82V4OMc1GXZUxnBPOahtdB8tx0qgOdoIzxikQgMS3QnOaieR94Hock0zzcnnv+RrK9h8pPJKSWweAcLTUlJj9FzxVYjDdcqDnFTDggHOOlNLqNIcSSeT+dOjXAJJxmnDlemcUoXC57jrWnQNiQKDjFJtHA9MmkXKqwx1pwyBvAPPGTRstSBr48tRxxzmoSADk5FSKcx4x0NMc5579RStcREFBfIPIz9KACEOe4pUU55yDSsDgbhSemxQxUzmlC84PT1pw+9x0Pakc/K3rS9AGEElgewpkeVXkdRRIWJwMccEVMmCvPXFWu4mVSoYDPXOaUoCcDj0pZVAzjtQfukHJ/rQgKzj5sjgHipQMFRkEY6U2RRsAzxTk+4M8kU9RsjmA3c96rkH73IGKtyAFcjPFQ7evuKVyS5fxh7LRwyEkWzcjt++lpiQQQqXwPm6VbnLrBpPCsv2Nwcn/ptJVVp0S0SEMhdBIzHIPXhR9MU2tbmaV/xKd3FHOCzKdi+nb/69VPsqMNzoS2Mg54qyriSJlA+RYtgIPBYnIP6UO2EjZ1b5Rk7sY/Ckoq9xtNaFSSFWJZkVVwevpVGZASrJHg9fZRV26ljllGAEzztU9qp+cqsVK5wOB3zSasTuRSk+bgEfKMgdjTQxZSq4VSOMelJK6qPm4cnrUReIMgDfMTgCobZfs2lciumPVzhR0FUp5ZGbO3aBwCT1rRlKvglDnvxUE21yF25x0BHAqBJorRuyjDHe1RPKFJ3nBA6ds1PPIIkwMFvWspoGfzN0pYnk4HSga1IpZzI7HdtA4X3qtPNMjRLEN2DyxHC1YMECNltzkdADxUkTscKoVR9M1d0ncLpbEsNr9oVWY8v3I6VM1msJURhd23Yox+v1PrVmwU71B9M1ZuSSVEKhpT93jhferjJmfNrYwfJmiDR7tpHzPgYxnoMevWq80ZZXG4CJV28jAP8A9YVpXmCoiaQbEOWZvvM3pn/OKyLqcLbspYifOAgHy47D3raLbL5upmXU3KBF2ov3ABjn+8apzzPgogODyzHqTVhmdgQVyW/E59Kuw2DHaz7cAfMT1zU3Y2jPtLIKN+OTXfaUAvgWwAP/ADEbv/0VbVyz7FUoBnHc11WlgN4Fs8D/AJiN3x/2ytqLuzFO2h7EOOfQU0vk7ScMOaDnfweD603GXDAdKlOxoh2RtPHSjaQCTyO1B4kJ7HsKeBlSaNiHuQB8OB271LGMEY6mhgrMDjNDHBDDqBRfWxZA3XI/Gk7nA5/pUpXKnvnvSL8x6D60XdtAI2AwFPUcVAF+Y59/pVqRTuGOgpkqEE4HTmk9QTKroWGCPaoCuCF9KuSYyc9etV8FivFQ1fc0uMKAdfSpDjeOBmnY5K46d6VY9ze+KdrBceBgDA465pyHsRxQqkKWB5A5zQvJQkYOM49aZLY8qdh4pgOQ3pT0Ydzj1qLd6Dg8/WgkDhRxjNMfoTj8KJBg+xANRliSBnikvIGPBzu7ioy2UIPWpGACKOhpDg7cDHvQBCzHII780jEng1KQuBxnFRuu38Tz9aWpStYYPmc9uM1J8vIHcUzjK459qeTgY7Z6032ENYDHbNNYDZu/MU6QHK7TyTTB94jt3pvcREU3ZBIPpx2p2RkjHBFKM54x0pucg+3pT1B9iN8gewNR8jp+NTuo24J/Ko1wx564otoDLmobWs9ILgEJbOx+bn/XS9qwJiFi8xQrdCwRcEHPGa19cOLXSMbgwtmJA9PPlx/n2qhGzKkZUjdng9ckdAfWtdLBF2j/AF3K6R91fkjJB9fan7Gw5yQ23adtE9vMUbBCuRzt42/h/SmhmUGN2wAMcD9ahibutDPuJPLlMbqWL9GPBAFQxKGIcRnOc9elX7raIi4UcttXPYAdTVdpwGjCqpJByemB6D0qdOpKfVIqPGj+YZVcbHCpk8Y6ninBoM7toyvy89hVaeYsQoAzj1NEVvujLNIRn09Ki7ltsVOdy1LdJ/ARnGdo7mqUju0eNu0nvUgiijCkDAPKg9SfWkaRERnkxnGAPeixj5ozZA0cuD83f61BcNuJCkDj9ammuVlkPyt6DiniESAYXgrnB9KixTbKZiAUHlgRxjvUkMcrMAExyBWklqSF3Nj0A71YVBEAABz2oZLaKsQ8puCC5OT6Cp532xOR8mQee/8A+uo5VkVt3Gf0z6VWkLGLIJdi3BHXNaRVwaW5VlVGwGxuAwMdR9PeqF1bfvGCIUIHJP8ACP8AE1olViw27MpHJHRfpVSVvO2gMSqnJUc8+p9armstCoq7K9laqjE7ckdDnrVqWNQowvB61a8naByAcYwKqygqCvU+3ek9C3oZd4wJx3H8q6jSW3eBbQjJ/wCJldj/AMhWtctepxuPUfpXRaU2PAVmAeP7TvMY/wCuVrWsV7rIbTaPbEO5e1K2NoJoA2YHbH5U1hkr6A5qDQZ91VAyAO9SFtuOm3rTGUtj6Urj939B0qidx6gNn6HrTSuOn0psW4YB5J4pwJLnI4FSUIDk8Hp1FKMc03GGO3r60/BHPbpilcGMwSwGPl60gXDknlcd6cB8x5560pG5hntzip2GQyIGJK9QMVWwN4Gast2Cnn+dR+V8zEdOx9KoaZGp2kDHXrUsagYJ+8TSxlSSGHtQvO5ugHFJag2Obr04qInD7h0xjNTgBowR0HGKiZco2eATxTvcRGCRuBPIo24GCMEjNJg7hnp3p64cMD1xjFSwIcltwOOBVeXK5ZeRnirQTg561Ceu0jjHOKaQXE8zO0kcZHNPU5YnmohjAVgeDUw+XgGk/MQxS2AO+TUb/ePHOaldgJD64qJhk5B5z0pLQrqMBGQcHHapSRkDIyRUQGDz2qQ4I471S0BkJJIIHSjdkjsc4pQAM56GmhuRxQtwDq3cDtTGJAC/hmrDLhcbccdagkx6ZyOKLiWpK33Pm6/zqDbzlcHmpCcryetCkDIpruIZrNoLi10p3fAFqygZ6/v5f0rNaHYQ4H3F+UemPSuivrG9nsNLa0sbq4X7Myl4omcA+bLxwPeqUekauYwraVfYHGDbuf6VbUmYc6XXv+ZlBzICAMyY4DHGP8TUahY5vLVmLY5J6Z/wrSfRdXEpY6VfbQOQts/J9uKrXeia4ytt0vUcn0tn4A9eKEm1sWpx2uY00m98P0HLHOO9VJZkJYEEALhcdTWs3h7XZIMHSNRGcFQLVwV/SmjwtrAjQf2RqRHRf9GfIHc9OKHDQpzhbcyY1DkKUAIGWIH86DJglSvA/wAitj/hHdbVdo0fUgg64tZOn5VTn8P687ZOiaoSTn/j0k4/So5H2MXOPczZXZmGSAVHOO3/ANequC4CAYUc8+vc1sR+GddbO3RNUAzyWtJOf0p//CLa7tYvo+pM2en2WT/CnyvsHMu5iR2qNtGAqDsan3LGwZc59O3tWjJ4a8QKTt0TU8e1rIefypYfC+vMTu0bUwPe1k6flU8r7Dc13M6N2YEHPr+FSDKgu3JA49q1G8N62pwui6ntx/z6ydfyqGTw14glfb/Y+p7fe1k/wqOWXYV0+piXNyzcYJBHB9vakjdyjblAVuMjjP8A9atz/hD9ccBW0jUQT3+zPx+lTt4T1sKn/Eq1EqDyv2V+f0qlGdtik4JbnKpZzO+5sEdgOgFWorVLZjsVfmOTXSL4Z1pCSmj6iM/9Or/4VBP4a1xyM6LqnHcWkn+FXGDXQbmnszmZ2IlP9apXDgNlGAf0rbufDPiJZS40DWGHtZyE/wAqoyeFvEpY48O6wff7DL/8TT5G9bBzxa1ZympyNlhnknvXQ6TJs8AWWec6pef+irSql94O8UyHI8N62fpYyn/2Wr93pGo6H4D0eHVrK5sp59RvZViuIzG+zy7YAkEZHKmtuW0Xchzi5JJ/1Y91l+6D3pjcx57k0UVibjh6dsZowDJz6UUU+oxp/wBZ9BxQCdxHaiiiWwuo8Abz7U09RRRWb2GxF++KB0zkkgmiikJEf3sE+uKQtlfTkjiiim9yluI3CcADinoAUZT93riiim9gY3oCB0HNL1ypAxkUUVC3AglOJRj1IpttyDn3ooq0Jjm5kH1qmjEvz34oopfaKWwo++p9RT34wR3oopMkjQby26mH7p+tFFKWlikIPmfB9KlIAb9aKKoCs/cetSRgeV+dFFDF0Hn77f7tQuBtQ0UUPYENYYXPoKaeDx3oopdRMV1G8UwAMWJHNFFAkRk/KKQkg/gaKKcSeoo5xQyhScUUVp1AjIAB4FNcDbuwMn2oopLZlkbHGcY6elR5zgnHX0ooqWJ7Av3+3NRynkcDmiiiWwluNLHzAvGMUpY8jjGcUUVXQkqufkP1qCToPaiitLKwdSuWOSO2az7mRiQCeKKKiOwIzLmRhnmqMsrFiDjGQKKKplSIWbPGB69KrzO2RyeetFFDJe5//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sclerotic lesions of morphea with overlying hypopigmented, finely wrinkled skin are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lichen sclerosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Oval porcelain-white plaques are present on the trunk of this patient with extragenital lichen sclerosus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lichen sclerosus - H&amp;E",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Epidermal atrophy, hyperkeratosis, hyalinization of the upper dermis, and a dermal lymphocytic infiltrate are present in this histopathologic specimen from a lesion of lichen sclerosus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26505=[""].join("\n");
var outline_f25_56_26505=null;
var title_f25_56_26506="Mechanisms of antibiotic resistance in enterococci";
var content_f25_56_26506=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mechanisms of antibiotic resistance in enterococci",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/56/26506/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/56/26506/contributors\">",
"     Cesar A Arias, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/56/26506/contributors\">",
"     Barbara E Murray, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/56/26506/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/56/26506/contributors\">",
"     David C Hooper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?25/56/26506/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?25/56/26506/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?25/56/26506/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enterococci, formerly called group D streptococci, come well equipped with a variety of intrinsic (ie, naturally occurring) antibiotic resistances; they are also capable of acquiring new resistance genes",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mutations. The combination of high-level resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    , and aminoglycosides is now fairly common among hospital-acquired Enterococcus faecium in the United States and has a major impact on therapeutic options (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27721?source=see_link\">",
"     \"Epidemiology, prevention and control of vancomycin-resistant enterococci\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Problems in the treatment of enterococcal infections were noticed as early as the 1950s with the observation that enterococcal endocarditis was not cured nearly as often as streptococcal endocarditis with penicillin [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/1\">",
"     1",
"    </a>",
"    ]. The reason for the poorer response appears to be that penicillin is not as bactericidal against enterococci as it is (or was in the 1950s) against most viridans streptococci. This phenomenon, which has been commonly described as tolerance, is characteristic of many enterococcal strains and, even in those that do not initially display tolerance, it can be rapidly elicited by pulsed (intermittent) penicillin exposure. The latter observation has led to some support for the use of continuous infusion penicillin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    in an attempt to avoid eliciting tolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENETICS OF RESISTANCE IN ENTEROCOCCI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the many intrinsic resistances of enterococci, most enterococcal infections, until recently, could be treated with penicillin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    with or without an aminoglycoside. Unfortunately, enterococci have now acquired resistance to these and many other agents as a result of mutations (eg, causing high-level resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    or to fluoroquinolones) or the acquisition of new gene(s).",
"   </p>",
"   <p>",
"    With respect to the acquisition of new genes, enterococci have several different ways of transferring DNA by conjugation (bacterial mating):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One mechanism, involving pheromone-responsive plasmids, causes plasmid transfer between E. faecalis isolates at a very high frequency [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another mechanism involves other plasmids that can transfer among a broad range of species and genera, although usually at a moderately low frequency [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A third mechanism (conjugative transposition) involves transfer of specialized transposons at low frequency but to a very broad range of different kinds of bacteria [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/5\">",
"       5",
"      </a>",
"      ]. Conjugative transposons are relatively nonselective in their host range and are one of the few types of elements known to have crossed the",
"      <span class=\"nowrap\">",
"       gram-positive/gram-negative",
"      </span>",
"      barrier in naturally occurring clinical isolates and to then cause resistance in these various hosts [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A fourth mechanism involves the transfer of large fragments of chromosomal DNA directly from one cell to the other via conjugation. The transfer appears to be dependent upon recombination occurring between homolog sequences present on pheromone-responsive plasmids and the chromosome [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many of the acquired resistances of enterococci involve antibiotics rarely used to treat enterococcal infections. These include tetracyclines, macrolides, high levels of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    , and fluoroquinolones. It seems likely that these resistances have emerged among enterococci that were colonizing humans or animals to whom antibiotics were given for other reasons.",
"   </p>",
"   <p>",
"    This observation serves as a reminder that the colonizing flora is at least as likely to be influenced by the use of antibiotics as is the infecting organism. Colonizing bacteria may actually be more capable of developing resistance because they coexist with multiple other bacterial species and therefore have access to their resistance genes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     BETA-LACTAM RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unlike many streptococci, an important intrinsic property of enterococci is their resistance to many beta-lactam compounds. The greatest degree of resistance is to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/25/43414?source=see_link\">",
"     aztreonam",
"    </a>",
"    , which lacks activity against all gram-positive cocci, and the cephalosporins (although new generation cephalosporins, such as ceftobiprole and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4628?source=see_link\">",
"     ceftaroline",
"    </a>",
"    , exhibit some activity against E. faecalis but not most E. faecium), followed by the antistaphylococcal penicillins such as methicillin, and the carboxypenicillins such as ticarcillin.",
"   </p>",
"   <p>",
"    Even with the more active beta-lactams (eg, penicillin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"     piperacillin",
"    </a>",
"    ), it takes 10 to 1000 times more drug to inhibit an average Enterococcus than an average Streptococcus. E. faecalis, the more susceptible of the two predominant enterococcal species, is usually inhibited by 1 to 4",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of ampicillin and 2 to 8",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of penicillin; the comparable minimal inhibitory concentrations (MICs) for E. faecium are typically 8 to 32",
"    <span class=\"nowrap\">",
"     mcg/mL.",
"    </span>",
"    However, E. faecium strains that are much more highly resistant to ampicillin have emerged in the past decade.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Ampicillin resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gene coding for penicillinase was first reported in staphylococci and later found, although rarely, in enterococci [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/8\">",
"     8",
"    </a>",
"    ]. Most penicillinase producing enterococci have been E. faecalis, but eight isolates of E. faecium from a polyclonal outbreak in Italy were reported to possess the beta-lactamase gene [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Relatively little penicillinase is produced by enterococci in comparison to most S. aureus, which can result in a problem of detection for the clinical laboratory. At the standard inoculum used for susceptibility testing, penicillinase-producing enterococci appear no more resistant to penicillin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    than a non-penicillinase producing organism; however, these organisms will show resistance at a high inoculum, when more enzyme is present (",
"    <a class=\"graphic graphic_table graphicRef57470 \" href=\"UTD.htm?40/62/41964\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    An in vivo effect of penicillinase has been demonstrated in animal models with a better response to penicillins in the presence of beta-lactamase inhibitors. The Clinical Laboratory Standards Institute (formerly called the National Committee for Clinical Laboratory Standards or NCCLS) currently recommends that, because of the rarity of penicillinase-positive enterococci, a test for penicillinase need not be performed routinely but can be used in selected cases, such as endocarditis and other serious infections [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/10\">",
"     10",
"    </a>",
"    ]. If recognized, these organisms pose no real therapeutic dilemma since they are susceptible to beta-lactamase inhibitor combinations, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/8/1160?source=see_link\">",
"     ampicillin-sulbactam",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24216?source=see_link\">",
"     piperacillin-tazobactam",
"    </a>",
"    , and to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    A more difficult problem is posed by enterococci with high-level resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    due to a non-penicillinase mechanism, since this resistance is not overcome by adding a beta-lactamase inhibitor. This phenotype is primarily seen in E. faecium. Isolates of this species recovered prior to the mid to late 1980s, although more resistant to ampicillin than E. faecalis, were usually inhibited by 8 to 32",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of ampicillin. More recently, a trend towards much higher levels of resistance has been observed among nosocomial isolates, with some strains failing to be inhibited by 256",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of ampicillin or more [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The intrinsic resistance of E. faecium appears to be due to the presence of a cell wall synthesis enzyme that is relatively resistant to inhibition by penicillin. This low-affinity penicillin binding protein (PBP) is called PBP5 and it exists in two versions [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. PBP5-R is characteristic of hospital-associated E. faecium with high MICs to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    and differs genetically by about 5 percent from PBP5-S, which is found in non-clinical or community-associated strains and demonstrates lower MICs to ampicillin. Higher levels of resistance to beta-lactam antibiotics appear to involve one or more of the following mechanisms: expression of PBP5-R, alterations in the PBP5 protein around the active site [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/14\">",
"     14",
"    </a>",
"    ], increased expression of PBP5, and utilization of a beta-lactam insensitive transpeptidase for cell wall synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A different PBP, PBP2a, is involved in methicillin resistance in Staphylococcus aureus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=see_link&amp;anchor=H5#H5\">",
"     \"Microbiology of methicillin-resistant Staphylococcus aureus\", section on 'Penicillin binding protein 2a'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     AMINOGLYCOSIDE RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enterococci are intrinsically resistant to low to moderate levels of aminoglycosides. The MIC of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    is usually 8 to 64",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    and that of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    is 64 to 512",
"    <span class=\"nowrap\">",
"     mcg/mL.",
"    </span>",
"    However, synergism is generally seen with these two compounds when enterococci are exposed to a combination of the aminoglycoside with a cell wall active agent, such as penicillin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    . In this setting, there is usually a marked increase in killing (&gt;100",
"    <span class=\"nowrap\">",
"     CFU/mL,",
"    </span>",
"    more killing than with penicillin alone), and a bactericidal effect (defined as &ge;1000",
"    <span class=\"nowrap\">",
"     CFU/mL",
"    </span>",
"    or a 99.9 percent decrease from the starting inoculum) is achieved by 24 hours.",
"   </p>",
"   <p>",
"    This synergistic effect presumably explains the clinical observation in the 1950s that a combination of penicillin with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    was much more effective for treatment of enterococcal endocarditis than penicillin alone [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/1\">",
"     1",
"    </a>",
"    ]. This regimen subsequently became the standard of care.",
"   </p>",
"   <p>",
"    In addition to the usual increased MICs of aminoglycosides for all enterococci to aminoglycosides, a naturally occurring characteristic of E. faecium is higher MICs of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/35/34352?source=see_link\">",
"     tobramycin",
"    </a>",
"    (MICs 64 to 1000",
"    <span class=\"nowrap\">",
"     mcg/mL)",
"    </span>",
"    and resistance to synergism with this aminoglycoside. This is due to the presence of an aminoglycoside modifying enzyme, a tobramycin 6'-acetyltransferase (AAC(6')-Ii), which modifies tobramycin but not",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/17\">",
"     17",
"    </a>",
"    ]. This enzyme eliminates synergism between cell wall active agents and tobramycin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/10/40102?source=see_link\">",
"     kanamycin",
"    </a>",
"    , netilmicin and sisomicin. Similarly, many enterococci possess the aph(3')-IIIa gene, which confers high-level resistance to kanamycin and abolishes the synergistic effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/16/34056?source=see_link\">",
"     amikacin",
"    </a>",
"    . Therefore, with minor exceptions, gentamicin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    are the only two aminoglycosides that should be considered to achieve synergistic therapy when treating enterococcal infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     High-level resistance to streptomycin and gentamicin",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the more serious of the acquired resistances of enterococci is high-level resistance to both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    . The significance of high-level resistance to these aminoglycosides is that it eliminates the synergism expected between gentamicin or streptomycin and a cell wall active agent such as penicillin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    A striking report of this phenomenon in 1959 described an enterococcus from a patient with endocarditis that was not killed by the combination of penicillin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/18\">",
"     18",
"    </a>",
"    ]. The patient had relapsing disease and was subsequently treated by penicillin plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/57/14229?source=see_link\">",
"     neomycin",
"    </a>",
"    (the only other aminoglycoside available at that time). This combination produced a clinical cure, it also produced deafness and resulted in an article entitled \"Deaf or dead\" [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/18\">",
"     18",
"    </a>",
"    ]. By 1970, a number of enterococcal isolates had acquired high-level resistance to streptomycin and to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/10/40102?source=see_link\">",
"     kanamycin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"       Streptomycin",
"      </a>",
"      resistance can be caused either by a ribosomal mutation, which leads to very high levels of resistance (MICs &gt;64,000",
"      <span class=\"nowrap\">",
"       mcg/mL),",
"      </span>",
"      or by the acquisition of a streptomycin-modifying enzyme (an adenylyltransferase), which usually produces MICs between 4000 and 16,000",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      (",
"      <a class=\"graphic graphic_table graphicRef57470 \" href=\"UTD.htm?40/62/41964\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"       Gentamicin",
"      </a>",
"      was found to be active against highly",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"       streptomycin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/10/40102?source=see_link\">",
"       kanamycin",
"      </a>",
"      resistant organisms and, by the mid-1970s, was being widely used for enterococcal endocarditis. However, since 1979, enterococci with high-level resistance to gentamicin have been increasingly reported [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/20\">",
"       20",
"      </a>",
"      ]. This resistance is most often due to the production of an enzyme with two functional regions: one with 2''-phosphotransferase activity; and one with 6'-acetyltransferase activity. These combined enzymatic activities result in high-level resistance",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      resistance to synergism to all commercially available aminoglycosides except streptomycin. The gene encoding this bifunctional enzyme,",
"      <span class=\"nowrap\">",
"       aph(2'')-Ia/aac(6')-Ie,",
"      </span>",
"      is identical to a gene previously found in staphylococci (",
"      <a class=\"graphic graphic_table graphicRef57470 \" href=\"UTD.htm?40/62/41964\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The co-occurrence of high-level resistance to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      and high-level resistance to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"       streptomycin",
"      </a>",
"      was reported in 1983, which documented for the first time strains of enterococci for which there was no known synergistic bactericidal regimen [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/21\">",
"       21",
"      </a>",
"      ]. The addition of any aminoglycoside to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"       ampicillin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      for such strains results in no more killing than ampicillin alone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Clinical Laboratory Standards Institute recommends screening of enterococci for high-level resistance (HLR) to both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/10\">",
"     10",
"    </a>",
"    ]. This is done by testing for growth at concentrations of 2000",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    and 500",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of streptomycin and gentamicin, respectively, on brain heart infusion agar (BHI); when using BHI broth, the recommended concentration for streptomycin is 1000",
"    <span class=\"nowrap\">",
"     mcg/mL.",
"    </span>",
"    Alternatively, disks of gentamicin 120 mcg (correlates with 500",
"    <span class=\"nowrap\">",
"     mcg/mL)",
"    </span>",
"    and streptomycin 300 mcg (correlates with 1000",
"    <span class=\"nowrap\">",
"     mcg/mL)",
"    </span>",
"    on Mueller-Hinton agar can be used. If the results with the disk diffusion test are not conclusive, HLR should be confirmed by other methods. Detection of HLR to both these compounds precludes the use of available aminoglycosides for synergism in any clinical situation.",
"   </p>",
"   <p>",
"    More recently, four new",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    resistance genes have been found that remain uncommon (",
"    <a class=\"graphic graphic_table graphicRef57470 \" href=\"UTD.htm?40/62/41964\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One, designated, aph (2\")-Ic, was found in a veterinary isolate of E. gallinarum with a",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      MIC of 256",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/23\">",
"       23",
"      </a>",
"      ] and has been found in an occasional E. faecium and E. faecalis with intermediate level resistance to gentamicin. The resulting enzyme is active against gentamicin and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/35/34352?source=see_link\">",
"       tobramycin",
"      </a>",
"      but is not very active against netilmicin or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/16/34056?source=see_link\">",
"       amikacin",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      The second gene, aph(2\")-Id, found in a few isolates of E. casseliflavus and E. faecium, confers high level resistance to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      , but the encoded enzyme is also not active against",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/16/34056?source=see_link\">",
"       amikacin",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      The third new",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      resistance gene, aph(2\")-Ib, found in E. faecium, was associated with MICs &gt;500",
"      <span class=\"nowrap\">",
"       mcg/mL",
"      </span>",
"      of gentamicin [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/22\">",
"       22",
"      </a>",
"      ]. It also conferred resistance to synergism with most aminoglycosides other than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/16/34056?source=see_link\">",
"       amikacin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"       streptomycin",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      A fourth gene encodes a 16S ribosomal RNA methyltransferase enzyme (designated EfmM) that appears to contribute to intrinsic aminoglycoside resistance in E. faecium [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/24\">",
"       24",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some data have shown that the combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    (or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"     cefotaxime",
"    </a>",
"    ) with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    may be effective in the treatment of endocarditis due to isolates of E. faecalis exhibiting high-level resistance to all aminoglycosides [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. An open label and non-randomized trial that involved 13 centers in Spain evaluated the efficacy of the combination and found that the overall clinical cure rate at 3 months was 67.4 percent. The rationale for the use of this combination is based on in vitro data that indicate that low concentrations of an amino-penicillin may be capable of partially saturating some penicillin-binding proteins (PBPs 4 and 5), but not PBPs 2 and 3 (which could still actively participate in the synthesis of the cell wall); cefotaxime (or ceftriaxone) could produce total saturation of PBPs 2 and 3, producing a bactericidal synergistic effect in E. faecalis (but not E. faecium) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TRIMETHOPRIM-SULFAMETHOXAZOLE AND CLINDAMYCIN RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other resistances that appear to be naturally occurring traits of E. faecalis include low-level resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    due to the presence of the gene lsa which encodes a putative ATP-binding protein [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/27\">",
"     27",
"    </a>",
"    ], and in vivo resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , despite in vitro susceptibility to this combination [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"     Trimethoprim",
"    </a>",
"    and sulfamethoxazole are both inhibitors of the synthesis of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    , a necessary component for bacterial growth and survival. In vivo resistance of enterococci to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    is due to the fact that these organisms, unlike most other bacteria, can use preformed folic acid, that is, folic acid which is present in humans and animals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     VANCOMYCIN RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both high and low-level resistance to glycopeptides can occur in enterococci. The definitions of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    susceptibility and resistance and the epidemiology of and infection control measures against vancomycin-resistant enterococci are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27721?source=see_link\">",
"     \"Epidemiology, prevention and control of vancomycin-resistant enterococci\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Low-level resistance to vancomycin",
"    </span>",
"    &nbsp;&mdash;&nbsp;An intriguing intrinsic feature of two enterococcal species &mdash; E. gallinarum and E. casseliflavus &mdash; is their capacity to express low level resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (MICs 8 to 16",
"    <span class=\"nowrap\">",
"     mcg/mL).",
"    </span>",
"    This is due to the presence of a cluster of chromosomal genes involved in the synthesis of serine-ending peptidoglycan precursors (vanC and vanT genes, encoding a D-alanyl:D-serine ligase and a serine racemase, respectively) as well as destruction of the \"normal\" D-alanine- ending peptidoglycan (the vanXYc gene encoding a bifunctional",
"    <span class=\"nowrap\">",
"     D,D-peptidase/D,D-carboxypeptidase",
"    </span>",
"    enzyme) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/30-32\">",
"     30-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The D-alanyl:D-serine ligase genes in both E. gallinarum and in E. casseliflavus (vanC-1 and vanC-2) are specific for these species and can be used to differentiate them from each other and from other enterococcal species [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. A third putative species, E. flavescens, has a gene that is almost identical to vanC-2 and many consider it the same species as E. casseliflavus [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many isolates of these species test susceptible to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    in vitro and even those which express resistance more fully are usually inhibited by 32",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of vancomycin. This low level of resistance is explained by the fact that the D-alanyl-D-serine terminus of peptidoglycan precursors has moderately reduced affinity for vancomycin [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/35\">",
"     35",
"    </a>",
"    ]. Some acquired van gene clusters can also confer low-level resistance to vancomycin by synthesizing peptidoglycan precursors ending in D-serine. These particular phenotypes include VanE, VanG, VanL, and VanN (",
"    <a class=\"graphic graphic_table graphicRef83403 \" href=\"UTD.htm?20/5/20573\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/36-39\">",
"     36-39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     High-level resistance to vancomycin",
"    </span>",
"    &nbsp;&mdash;&nbsp;High-level",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance is the most problematic resistance of enterococci, because it often appears in strains already highly resistant to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    (primarily E. faecium) (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14314?source=see_link\">",
"     \"Treatment of enterococcal infections\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Despite our awareness of the propensity of enterococci to acquire antibiotic resistance, the emergence of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance in the late 1980s was unanticipated. The surprise derived largely from the fact that vancomycin had been commercially available for over thirty years without high-level resistance ever being seen. However, the drug did not begin to receive substantial clinical use until the late 1970s and early 1980s when methicillin-resistant S. aureus, methicillin-resistant coagulase negative staphylococci, and Clostridium difficile became pathogens of major concern in the United States.",
"   </p>",
"   <p>",
"    When one examines the complex nature of the mechanism of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance and the diverse number of vancomycin resistance gene clusters, it seems most likely that resistance arose in the distant past, perhaps in response to glycopeptides (which are natural products) present in the environment, and has now been selected for in clinically relevant organisms by the commercial use of glycopeptide antibiotics. Consistent with this hypothesis is the identification of soil organisms (Paenibacillus thiaminolyticus and P. apiarius) that harbor vancomycin resistance genes that are almost identical to those of enterococci [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Mechanism of high-level resistance to vancomycins",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     Vancomycin",
"    </a>",
"    inhibits enterococci by binding to the D-alanyl-D-alanine (D-Ala-D-Ala) terminus of cell wall precursors, compromising the subsequent enzymatic steps in the synthesis of cell wall. High-level resistance to vancomycin is encoded by different clusters of genes referred to as the vancomycin resistance gene clusters (eg, vanA, B, D and M gene clusters).",
"   </p>",
"   <p>",
"    The end result is the replacement of D-Ala-D-Ala-ending peptidoglycan precursors with D-alanyl-D-lactate termini, to which",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    binds with significantly lower affinity [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/35\">",
"     35",
"    </a>",
"    ]. The replacement of D-alanine by D-lactate, which disrupts one of the five hydrogen bonds required for the interaction of vancomycin with its target, increases the MIC of this antibiotic almost 1000-fold.",
"   </p>",
"   <p>",
"    The three major phenotypes, VanA, VanB, and VanD, can sometimes be differentiated by the level of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance, susceptibility to the glycopeptide antibiotic teicoplanin, and whether the resistance is induced by exposure to teicoplanin (",
"    <a class=\"graphic graphic_table graphicRef83403 \" href=\"UTD.htm?20/5/20573\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/41\">",
"     41",
"    </a>",
"    ]. Accurate discrimination of these phenotypes can be achieved by identification of the corresponding genes using polymerase chain reaction (PCR) or hybridization techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    VanF is a phenotype described in Paenibacillus popilliae, a biopesticidal agent used in agriculture. The",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance gene cluster (vanF) has 77 percent homology with the vanA gene cluster and it has been postulated that these genes were originally transferred from P. popilliae to enterococci [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/43\">",
"     43",
"    </a>",
"    ]. Other members of the Paenibacillus and Rhodococcus family also harbor genes homologous to vanA [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    VanA is the most common type of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance, usually mediates higher levels of resistance than other types, and causes cross-resistance to teicoplanin. The vanA gene cluster is typically found on a transposon identical or related to Tn1546 which, in turn, is often found within a plasmid [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/41\">",
"     41",
"    </a>",
"    ]. The vanA cluster has disseminated to other bacterial species, including clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Several isolates of these vancomycin-resistant Staphylococcus aureus have been reported in various countries. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16425?source=see_link&amp;anchor=H7#H7\">",
"     \"Vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections\", section on 'VRSA'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These findings emphasize the fact that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    -resistance gene clusters can overcome the species barrier and disseminate to several bacterial species limiting the therapeutic options even further.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     VanA phenotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;The genes encoding the VanA phenotype (vanS, R, H, A, X, Y, Z) have been best studied [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/41,45\">",
"     41,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The vanS and vanR genes encode a two-component regulatory system that is involved in the induction of expression of resistance. VanS senses the presence or perhaps an effect of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      and then signals to the response regulator, VanR, to turn on the expression of three genes vanA, vanH and vanX, which are necessary and sufficient for resistance.",
"     </li>",
"     <li>",
"      VanH (encoded by the gene, vanH) is a dehydrogenase that generates significant quantities of D-lactate for peptidoglycan synthesis.",
"     </li>",
"     <li>",
"      VanA (encoded by the vanA gene) is a ligase that catalyzes the binding of D-alanine to D-lactate (the corresponding ligases in other types are VanB, VanD, VanF, and VanM), resulting in the formation of D-alanyl-D-lactate. This moiety is then added by endogenous enterococcal enzymes to a tripeptide cell wall precursor. As a consequence, a pentapeptide precursor ending in D-Ala-D-Lac (pentadepsipeptide) is synthesized.",
"     </li>",
"     <li>",
"      The formation of a D-Ala-D-Lac containing precursor is not sufficient to cause resistance to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      if the cell continues to produce the normal cell wall precursor ending in D-Ala-D-Ala. VanX and VanY complete the resistance profile. VanX is a D,D-dipeptidase which cleaves D-Ala-D-Ala [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/46\">",
"       46",
"      </a>",
"      ]. Any D-Ala-D-Ala dipeptide that escapes this dipeptidase activity and is incorporated into cell wall precursors is removed by VanY. VanY is a D,D-carboxypeptidase, which cleaves the terminal D-Ala from the cell wall precursor, leaving a tetrapeptide precursor that can be utilized for cell wall synthesis but to which vancomycin does not bind [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The function encoded by vanZ is not known although, when cloned alone, it confers teicoplanin resistance onto the host strain [",
"      <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     VanB phenotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;The VanB phenotype, the second most common type, is less frequently encountered than VanA. Some enterococci with this phenotype will be missed if concentrations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    used for screening are too high (&gt;20",
"    <span class=\"nowrap\">",
"     mcg/mL)",
"    </span>",
"    (",
"    <a class=\"graphic graphic_table graphicRef83403 \" href=\"UTD.htm?20/5/20573\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The major phenotypic difference between VanA- and VanB-producing strains is that teicoplanin is not a good inducer of expression of the genes in the vanB cluster; as a result, vanB-containing bacteria usually test teicoplanin susceptible. However, mutations can and do occur spontaneously within the vanB cluster that result in teicoplanin-resistant derivatives.",
"   </p>",
"   <p>",
"    Most of the genes in the vanB gene cluster have homologs to genes in the vanA cluster and appear to function in a similar manner to produce a cell wall precursor ending in D-Ala-D-Lac. However, the vanB gene cluster has a distinct gene, vanW, it has no vanZ, and its vanY gene is in a different location. Although this phenotype was originally reported as nontransferable, there are now a number of reports of strain to strain transfer of the vanB gene cluster as part of large (90 to 250 kb) chromosomally-located mobile elements and as part of plasmids. The vanB gene cluster has been observed in Streptococcus bovis (this biotype of S. bovis has been reclassified as Streptococcus gallolyticus) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/48\">",
"     48",
"    </a>",
"    ] and in anaerobic bacteria (Eggerthella lenta and Clostridium inoculum) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some isolates of E. faecium that carry the vanA gene cluster but express the VanB phenotype have been described in Southeast Asia [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/50\">",
"     50",
"    </a>",
"    ]. These isolates usually harbor insertions or deletions in the in the vanY, vanX, vanZ or vanR genes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Vancomycin dependence",
"    </span>",
"    &nbsp;&mdash;&nbsp;An interesting, and not rare, variation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance is that of vancomycin dependence. Vancomycin dependent enterococci (VDE) evolve from vancomycin-resistant strains, usually from those that contain the vanB gene cluster. These organisms have lost the ability to make their native cell wall, which contains D-Ala-D-Ala termini; as a result, they are dependent upon the continued production of peptidoglycan termini containing D-Ala-D-Lac. Because the vancomycin resistance genes are normally inducible, the D-Ala-D-Lac-ending peptidoglycan is synthesized only when vancomycin is present (eg, in a patient receiving vancomycin therapy or when vancomycin is added to the in vitro culture medium).",
"   </p>",
"   <p>",
"    A number of patients have been described with VDE that appear to have negative cultures, unless the samples are cultivated in the presence of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/51\">",
"     51",
"    </a>",
"    ]. In one instance, blood cultures, drawn while the patient was on vancomycin, grew in the initial blood culture bottle but failed to grow on subculture, except around a vancomycin antibiotic disk. Although stopping vancomycin therapy may be of temporary benefit, VDE can revert to non-dependence but are still vancomycin resistant. They can revert by either becoming constitutive producers of the D-Ala-D-Lac containing cell wall by a mutation that restores the activity of the intrinsic D-Ala:D-Ala ligase or by mutations in the transcriptional terminator region of the regulatory genes resulting in expression of the resistance genes in the absence of vancomycin [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     LINEZOLID RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     Linezolid",
"    </a>",
"    is active against gram-positive bacteria including enterococci and staphylococci. Its mechanism of action involves the inhibition of protein synthesis by the interaction with 23S ribosomal RNA (rRNA) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/54\">",
"     54",
"    </a>",
"    ]. Linezolid interferes with the positioning of the aminoacyl-tRNA in the A site of the bacterial ribosomes [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     Linezolid",
"    </a>",
"    resistance has been reported in clinical isolates of both staphylococci and enterococci [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/56-59\">",
"     56-59",
"    </a>",
"    ]. In enterococci, the G2576U (E. coli numbering scheme) mutation in domain V of the 23S rRNA is the most common mutation associated with resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/59-61\">",
"     59-61",
"    </a>",
"    ]. Since bacteria carry several copies of the 23S rRNA gene, the number of rRNA genes mutated appears to be an important determinant of resistance (gene dosage effect); the MIC increases in proportion to the number of mutated genes [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. The linezolid dose and length of treatment influences the number of mutated genes and the resistance phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subsequently, plasmid-mediated resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    was described in US human clinical isolates of staphylococci [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/63\">",
"     63",
"    </a>",
"    ]. The mechanism of resistance involves the methylation of an adenine at position 2503 (A2503) of the 23S rRNA. This modification is carried out by a methyltransferase (designated Cfr, for chloramphenicol-florfenicol resistance) [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. The cfr gene was previously found in the chromosome of an MRSA strain recovered from the sputum of a patient who died of a nosocomial pneumonia in Colombia [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/66\">",
"     66",
"    </a>",
"    ]; analysis of DNA from the cfr region of the Colombian isolate suggested that the MRSA strain may have acquired this gene through an enterococcal donor [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/64\">",
"     64",
"    </a>",
"    ]. Furthermore, the cfr gene has been described in a clinical isolate of E. faecalis from animal origin in China and on a transferable plasmid from a human isolate of E. faecalis recovered from a patient in Thailand [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/67,68\">",
"     67,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Oxazolidinone resistance amongst enterococcal isolates has been increasingly documented [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/69-71\">",
"     69-71",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     Linezolid",
"    </a>",
"    resistance was initially described sporadically and it was associated with prolonged use of the antibiotic [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/57\">",
"     57",
"    </a>",
"    ]. In a study from Chicago, linezolid-resistant VRE was described in five patients (four renal transplant recipients), usually after more than 21 days of therapy and often in patients who had received several courses of other antimicrobials [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Horizontal spread of specific",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    -resistant outbreak strains has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. In one study, the risk factors associated with the acquisition of LRE included administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24216?source=see_link\">",
"     piperacillin-tazobactam",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/33/16919?source=see_link\">",
"     cefepime",
"    </a>",
"    , peripheral vascular disease,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    and receipt of a solid organ transplant [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/69\">",
"     69",
"    </a>",
"    ]. Although it is evident that the emergence of linezolid resistance is associated with the heavy use of this antibiotic, LRE have been isolated from patients without previous exposure to the antibiotic [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DAPTOMYCIN RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     Daptomycin",
"    </a>",
"    is a cyclic semisynthetic lipopeptide antibiotic that is active against a wide variety of Gram-positive bacteria. It has potent bactericidal activity mainly due to its ability to penetrate the bacterial cell wall and insert into the cytoplasmic membranes in a calcium-dependent manner, causing alterations in the cell membrane potential with leakage of potassium [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     Daptomycin",
"    </a>",
"    is currently approved for the treatment of skin and skin-structure infections caused by susceptible Gram-positive infections and bacteremia due to Staphylococcus aureus [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/74\">",
"     74",
"    </a>",
"    ]. Although daptomycin is not currently approved to treat VRE infections, it has been used successfully for the treatment of a variety of VRE infection, including soft tissue infections [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/75\">",
"     75",
"    </a>",
"    ] and bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     daptomycin",
"    </a>",
"    has been increasingly reported in enterococci, including isolates from patients who have never received the antibiotic [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/77-80\">",
"     77-80",
"    </a>",
"    ]. Initial insights into the mechanisms of daptomycin resistance in enterococci have been provided by a study in which whole genome sequencing was performed on E. faecalis isolates from a patient with fatal bacteremia before and after daptomycin therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/81\">",
"     81",
"    </a>",
"    ]. The development of daptomycin resistance by this clinical isolate was directly linked to mutations in genes encoding the following putative enzymes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      LiaF, a member of three-component regulatory system (LiaFSR) involved in the bacterial cell-envelope response to antibiotics and antimicrobial peptides",
"     </li>",
"     <li>",
"      GdpD, a glycerol-phosphodiester phosphodiesterase enzyme that is likely to be involved in cell membrane phospholipid metabolism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The same study also found mutations in liaFSR in separate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     daptomycin",
"    </a>",
"    -resistant clinical isolates of E. faecium, suggesting a common mechanism. A mutation in a third gene encoding a putative cardiolipin synthase enzyme was also detected in the daptomycin-resistant isolate of E. faecalis, although the contribution of this mutation to daptomycin resistance is yet to be determined. A different cardiolipin synthase mutation was associated with development of daptomycin resistance in vitro, however, this mutation only conferred higher MIC to daptomycin when the mutated allele was overexpressed in the daptomycin-susceptible parental strain [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     Daptomycin",
"    </a>",
"    failure as monotherapy in the treatment of VRE endocarditis without evident development of resistance (ie, lack of increase in MIC) has also been documented [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     QUINUPRISTIN-DALFOPRISTIN RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/17/34068?source=see_link\">",
"     Quinupristin-dalfopristin",
"    </a>",
"    is a mixture of two chemically unrelated compounds from the streptogramin family that act synergistically. Quinupristin-dalfopristin inhibits protein synthesis in bacteria by interfering with different targets on the rRNA 23S in the 50S ribosomal subunit [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/84\">",
"     84",
"    </a>",
"    ]. The mechanism of synergy appears to be based on ribosomal conformational changes provoked by the binding of the streptogramin A (dalfopristin), which can cause irreversible attachment of the streptogramin B (quinupristin) to the ribosome [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/17/34068?source=see_link\">",
"     Quinupristin-dalfopristin",
"    </a>",
"    is administered parenterally and has activity against staphylococci, pneumococci and Enterococcus faecium. Isolates of E. faecalis are resistant due to the presence of the lsa gene, which also confers low level resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Trimethoprim-sulfamethoxazole and clindamycin resistance'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/17/34068?source=see_link\">",
"     quinupristin-dalfopristin",
"    </a>",
"    among E. faecium can occur by several mechanisms. These include enzymatic modification, active transport (efflux mediated by an ATP-binding pump), and target modification [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/84\">",
"     84",
"    </a>",
"    ]. Full resistance in clinical isolates appears to require a combination of mechanisms. However, resistance to dalfopristin alone is sufficient to dramatically reduce efficacy of the combined antibiotic and decrease the bactericidal effect. The vatD and vatE genes, which encode acetyltransferases that inactivate dalfopristin, are frequently found in resistant E. faecium isolates [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. These genes are found on transposable genetic elements, where they are sometimes associated with the erm genes that confer parallel resistance to streptogramin B-class (quinupristin) compounds [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/88,89\">",
"     88,89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In clinical trials of E. faecium infections, resistance emerged during",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/17/34068?source=see_link\">",
"     quinupristin-dalfopristin",
"    </a>",
"    therapy in 5 out of 396 patients; four of these cases resulted in treatment failure [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/90\">",
"     90",
"    </a>",
"    ]. Similarly, the Centers for Disease Control and Prevention have reported that the prevalence of quinupristin-dalfopristin resistance in E. faecium from human stools was 1 to 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of the related compound virginiamycin has had a direct impact on the emergence of resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/17/34068?source=see_link\">",
"     quinupristin-dalfopristin",
"    </a>",
"    in animal husbandry [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/84\">",
"     84",
"    </a>",
"    ]. Indeed, a gene (vgbB) encoding the virginiamycin B lyase is capable of hydrolyzing quinupristin [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/92\">",
"     92",
"    </a>",
"    ]. As a result, virginiamycin has been banned in Europe since 1999.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TIGECYCLINE RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/7/40053?source=see_link\">",
"     Tigecycline",
"    </a>",
"    is the 9-t-butylglycylamido derivative of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    , approved for the treatment of complicated skin and soft tissue infections and abdominal infections caused by susceptible organisms, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    -susceptible E. faecalis. This compound does not have an approved indication for the treatment of VRE or any E. faecium infection. Resistance to tigecycline has been documented in an E. faecalis isolate recovered from the urine of a 65-year-old patient who underwent intra-abdominal surgery following a femoral neck fracture and received a prolonged course of tigecycline for the treatment of nosocomial pneumonia due to Stenotrophomonas maltophilia; however, the mechanism of resistance has not been described [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DETECTION OF ANTIBIOTIC RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the difficulty in detecting some resistances of enterococci using standard laboratory methods, several special tests are recommended for these organisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Beta-lactam resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nitrocefin, a specific beta-lactamase test, is recommended for detecting the rare beta-lactamase producing Enterococcus among isolates from endocarditis and other serious infections [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/94\">",
"     94",
"    </a>",
"    ]. Susceptibility testing at a high inoculum is also effective at detecting penicillin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    resistance since more enzymes will be present; as noted above, these organisms will generally not appear resistant when tested at the standard inoculum. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Beta-lactam resistance'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Vancomycin resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;To detect",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance, enterococci can be inoculated onto BHI agar containing vancomycin 6",
"    <span class=\"nowrap\">",
"     mcg/mL,",
"    </span>",
"    followed by incubation for 24 hours at 35&ordm;C. This screening test should detect vanA and most vanB containing enterococci, but may also detect some organisms with the vanC phenotype. If MICs are determined, incubation for a full 24 hours is recommended (rather than 16 to 20 hours which is commonly used) with careful examination for even faint growth [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/94\">",
"     94",
"    </a>",
"    ]. For isolates intermediate in susceptibility (MIC 8 to 16",
"    <span class=\"nowrap\">",
"     mcg/mL),",
"    </span>",
"    identification to the species level is suggested by the Clinical Laboratory Standards Institute (formerly NCCLS) to identify the intrinsically resistant species, E. casseliflavus and E. gallinarum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Vancomycin dependence",
"    </span>",
"    &nbsp;&mdash;&nbsp;VDE may be detected by incorporating",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (eg, 6",
"    <span class=\"nowrap\">",
"     mcg/mL)",
"    </span>",
"    into BHI or agar or by adding a disk to an agar surface. Commercial agar for detection of VRE will suffice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Aminoglycoside resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;For aminoglycoside testing, BHI agar with 500",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    or 2000",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    or BHI broth with 500",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of gentamicin or 1000",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of streptomycin is recommended to detect resistance to synergism. For streptomycin-containing media, if there is no growth at 24 hours, plates or wells should be reincubated for an additional 24 hours. Paper disks containing large quantities of aminoglycosides are commercially available in Europe, but have not yet been approved in the United States.",
"   </p>",
"   <p>",
"    Most enterococci with high-level resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    grow just as well on 2000",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    as on 500",
"    <span class=\"nowrap\">",
"     mcg/mL,",
"    </span>",
"    but 500",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    is used because it is sufficient to differentiate intrinsically-resistant enterococci (MICs &lt;64",
"    <span class=\"nowrap\">",
"     mcg/mL)",
"    </span>",
"    from strains with acquired resistance and it is less costly since it uses less reagent.",
"   </p>",
"   <p>",
"    For",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    , MICs of intrinsically-resistant strains can be as high as 256 to 512",
"    <span class=\"nowrap\">",
"     mcg/mL;",
"    </span>",
"    as a result, higher concentrations must be used to distinguish acquired from intrinsic resistance to this drug. However, 2000",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    in broth has failed to support adequate growth of some resistant strains due to production of streptomycin adenylyltransferase; this observation has led to the use of 1000",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    in this medium. BHI medium is recommended because it better supports growth than Mueller-Hinton medium.",
"   </p>",
"   <p>",
"    Aminoglycosides other than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    need not be tested. Furthermore, the results may be misleading. As an example, MICs of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/16/34056?source=see_link\">",
"     amikacin",
"    </a>",
"    cannot distinguish intrinsically-resistant strains from strains that have acquired the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/10/40102?source=see_link\">",
"     kanamycin",
"    </a>",
"    -",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/57/14229?source=see_link\">",
"     neomycin",
"    </a>",
"    phosphotransferase, which causes resistance to synergism with amikacin. In addition, difficulties with E. faecium and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/35/34352?source=see_link\">",
"     tobramycin",
"    </a>",
"    were described above; strains of this species produce tobramycin 6'-acetyltransferase, which modifies tobramycin but not gentamicin [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Aminoglycoside resistance'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    One word of caution relates to strains with intermediate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    resistance mediated by the newly described gene, aph(2'')-Ic, which confers resistance to synergism with gentamicin [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/23\">",
"     23",
"    </a>",
"    ]. Strains described to date showed growth of 1 to 15 colonies on agar plates with 500",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    of gentamicin. This is far less than the confluent growth usually observed with strains with high-level resistance to gentamicin and may therefore be overlooked. In addition, this enzyme did not seem to interfere with synergism with netilmicin, unlike the bifunctional enzyme. Similarly, APH (2\")-Id is not active against",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/16/34056?source=see_link\">",
"     amikacin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Resistance differences related to species",
"    </span>",
"    &nbsp;&mdash;&nbsp;A characteristic of E. faecium that is not detected by routine antimicrobial testing is the intrinsic resistance of members of this species to synergism between cell wall active agents and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/35/34352?source=see_link\">",
"     tobramycin",
"    </a>",
"    . There is no established clinical laboratory test to identify this property except for identification of the species or performance of time-kill curves.",
"   </p>",
"   <p>",
"    An expanded range MIC determination might be helpful. However, concentrations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/35/34352?source=see_link\">",
"     tobramycin",
"    </a>",
"    would have to be higher than those used for other organisms and it would not be practical for clinical laboratories to have such a test available, particularly since alternative aminoglycosides can be used and their resistance can be detected by routine methods. More recently, a gene probe to detect the gene (aac(6')-Ii) responsible for resistance to tobramycin synergism [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/17\">",
"     17",
"    </a>",
"    ] has been used as a reliable method for identifying E. faecium with this property [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another characteristic species difference is that higher levels of resistance to penicillins and carbapenems are typically seen in E. faecium and E. raffinosus (which is very similar biochemically to E. avium) compared to other enterococcal species. This resistance is almost",
"    <strong>",
"     never",
"    </strong>",
"    due to beta-lactamase production, which is uncommon in general in enterococci and is extremely rare in non-E. faecalis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     E. gallinarum and E. casseliflavus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential of E. gallinarum and E. casseliflavus to express low-level resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    is another characteristic difference among enterococcal species. Whether members of these species that test susceptible to vancomycin can be adequately treated by this antibiotic is not known; however, since they are typically susceptible to penicillin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    , the use of one of these agents would be more prudent.",
"   </p>",
"   <p>",
"    The recovery of E. gallinarum and E. casseliflavus strains with low-level",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance is not an indication for isolation of the patient, since the intrinsic resistance is not found on plasmids or transposons that might spread to other bacteria. Nonetheless, the description of a hospital-wide outbreak caused by a strain of E. gallinarum suggests that isolation may be useful when dissemination of a virulent strain is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although vanA, which has propensity to be on transferable elements, has appeared in both E. gallinarum and E. casseliflavus, transmission of infection has been rare. The presence of vanA in E. gallinarum causes higher levels of resistance than seen with the VanC phenotype, as well as resistance to teicoplanin [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/97\">",
"     97",
"    </a>",
"    ]. As a result, the presence of vanA can be distinguished from the intrinsic low-level VanC-resistant phenotype.",
"   </p>",
"   <p>",
"    VanB, which can also cause low-level",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    resistance, has not been reported in either of these two species.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Daptomycin resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     Daptomycin",
"    </a>",
"    requires the presence of physiologic levels of calcium ions (50",
"    <span class=\"nowrap\">",
"     mcg/mL)",
"    </span>",
"    for maximum activity. As a result, the Clinical Laboratory Standards Institute recommends only the broth dilution method with Mueller-Hinton broth adjusted to a final calcium ion concentration of 50",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/94\">",
"     94",
"    </a>",
"    ]. Calcium-supplemented daptomycin Etest strips also appear to be an accurate method to detect daptomycin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?25/56/26506/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95066433\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Enterococci can develop resistance through mutations as well as acquisition of new genes on plasmids and transposons that can cross species and genera. Many of the acquired resistances likely emerged among enterococci colonizing humans or animals that were given antibiotics for other reasons. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Genetics of resistance in enterococci'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Enterococci have intrinsic resistance to many beta-lactam compounds, particularly cephalosporins.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"       Ampicillin",
"      </a>",
"      resistance in E. faecalis can be caused by penicillinase, which can be overcome with the addition of a beta-lactamase inhibitor. E. faecium is intrinsically resistant to ampicillin due to the presence of a low-affinity penicillin binding protein and thus is not susceptible to beta-lactamase inhibitor combinations. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Beta-lactam resistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Enterococci have intrinsic low to moderate level of resistance to aminoglycosides, but",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"       streptomycin",
"      </a>",
"      retain synergistic activity against enterococci when combined with a cell wall agent. When high-level resistance to one of these aminoglycosides is present (eg, through ribosomal mutations or acquisition of modifying enzymes) the synergistic effect of that agent is eliminated. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Aminoglycoside resistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although enterococci may be susceptible in vitro to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      , they seem to be resistant in vivo due to their capacity to utilize preformed",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Trimethoprim-sulfamethoxazole and clindamycin resistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Resistance to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      develops through alteration of its binding site, the D-alanyl-D-alanine terminus of cell wall precursors. Production of D-alanyl-D-lactate ending peptidoglycans, for which vancomycin has significantly reduced affinity, confers high-level vancomycin resistance, primarily seen in E. faecium. The vancomycin resistance gene clusters that encode high-level resistance can disseminate to other bacterial species. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Vancomycin resistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Enterococcal resistance to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"       linezolid",
"      </a>",
"      is acquired through mutation and possibly enzyme modification of the ribosomal RNA target. The emergence of resistance is generally associated with the heavy use of linezolid, although resistant enterococci have been isolated from patients without previous exposure to the antibiotic. The emergence of linezolid resistance in enterococci through transferable plasmids carrying the cfr gene raises concern of spreading linezolid resistance to other strains and species. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Linezolid resistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Resistance to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"       daptomycin",
"      </a>",
"      has been reported after prolonged daptomycin exposure. The mechanism of resistance involves mutations in genes associated with the regulation of the cell envelope response to antibiotics and cell membrane phospholipid metabolism. Clinical failure of daptomycin in endocarditis due to enterococci with apparent in vitro susceptibility to the drug has been reported; the mechanism is unknown. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Daptomycin resistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      E. faecalis are naturally resistant to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/17/34068?source=see_link\">",
"       quinupristin-dalfopristin",
"      </a>",
"      due to the presence of the lsa gene, which encodes a putative ATP-binding efflux protein. Resistance to quinupristin-dalfopristin among E. faecium can occur by enzyme modification, hydrolysis, active transport, and target modification. &nbsp;Resistance to dalfopristin alone dramatically reduces efficacy of the combined antibiotic and decreases the bactericidal effect. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Quinupristin-dalfopristin resistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Certain special tests are recommended for evaluating resistances of enterococci that are difficult to detect with standard laboratory methods. &nbsp;Susceptibility testing at a high inoculum can better detect penicillin and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"       ampicillin",
"      </a>",
"      resistance. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Detection of antibiotic resistance'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/1\">",
"      GERACI JE, MARTIN WJ. Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis; clinical, pathologic and therapeutic consideration of 33 cases. Circulation 1954; 10:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/2\">",
"      Hodges TL, Zighelboim-Daum S, Eliopoulos GM, et al. Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens. Antimicrob Agents Chemother 1992; 36:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/3\">",
"      Dunny GM, Leonard BA, Hedberg PJ. Pheromone-inducible conjugation in Enterococcus faecalis: interbacterial and host-parasite chemical communication. J Bacteriol 1995; 177:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/4\">",
"      Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/5\">",
"      Clewell DB, Gawron-Burke C. Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Annu Rev Microbiol 1986; 40:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/6\">",
"      Roberts MC. Characterization of the Tet M determinants in urogenital and respiratory bacteria. Antimicrob Agents Chemother 1990; 34:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/7\">",
"      Manson JM, Hancock LE, Gilmore MS. Mechanism of chromosomal transfer of Enterococcus faecalis pathogenicity island, capsule, antimicrobial resistance, and other traits. Proc Natl Acad Sci U S A 2010; 107:12269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/8\">",
"      Murray BE. Beta-lactamase-producing enterococci. Antimicrob Agents Chemother 1992; 36:2355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/9\">",
"      Sarti M, Campanile F, Sabia C, et al. Polyclonal diffusion of beta-lactamase-producing Enterococcus faecium. J Clin Microbiol 2012; 50:169.",
"     </a>",
"    </li>",
"    <li>",
"     Clinical Laboratory Standards Institute. Performance standards for antimicrobial testing: Twentieth informational supplement. Document M100-S20, Clinical Laboratory Standards Institute; Wayne, PA 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/11\">",
"      Grayson ML, Eliopoulos GM, Wennersten CB, et al. Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 1991; 35:2180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/12\">",
"      Fontana R, Ligozzi M, Pittaluga F, Satta G. Intrinsic penicillin resistance in enterococci. Microb Drug Resist 1996; 2:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/13\">",
"      Galloway-Pe&ntilde;a JR, Rice LB, Murray BE. Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time. Antimicrob Agents Chemother 2011; 55:3272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/14\">",
"      Rice LB, Bellais S, Carias LL, et al. Impact of specific pbp5 mutations on expression of beta-lactam resistance in Enterococcus faecium. Antimicrob Agents Chemother 2004; 48:3028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/15\">",
"      Mainardi JL, Legrand R, Arthur M, et al. Novel mechanism of beta-lactam resistance due to bypass of DD-transpeptidation in Enterococcus faecium. J Biol Chem 2000; 275:16490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/16\">",
"      Mainardi JL, Morel V, Fourgeaud M, et al. Balance between two transpeptidation mechanisms determines the expression of beta-lactam resistance in Enterococcus faecium. J Biol Chem 2002; 277:35801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/17\">",
"      Costa Y, Galimand M, Leclercq R, et al. Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium. Antimicrob Agents Chemother 1993; 37:1896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/18\">",
"      HAVARD CW, GARROD LP, WATERWORTH PM. Deaf or dead? A case of subacute bacterial endocarditis treated with penicillin and neomycin. Br Med J 1959; 1:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/19\">",
"      Eliopoulos GM, Farber BF, Murray BE, et al. Ribosomal resistance of clinical enterococcal to streptomycin isolates. Antimicrob Agents Chemother 1984; 25:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/20\">",
"      Courvalin P, Carlier C, Collatz E. Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci. J Bacteriol 1980; 143:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/21\">",
"      Mederski-Samoraj BD, Murray BE. High-level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis 1983; 147:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/22\">",
"      Chow JW. Aminoglycoside resistance in enterococci. Clin Infect Dis 2000; 31:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/23\">",
"      Chow JW, Zervos MJ, Lerner SA, et al. A novel gentamicin resistance gene in Enterococcus. Antimicrob Agents Chemother 1997; 41:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/24\">",
"      Galimand M, Schmitt E, Panvert M, et al. Intrinsic resistance to aminoglycosides in Enterococcus faecium is conferred by the 16S rRNA m5C1404-specific methyltransferase EfmM. RNA 2011; 17:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/25\">",
"      Gavald&agrave; J, Len O, Mir&oacute; JM, et al. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med 2007; 146:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/26\">",
"      Tascini C, Doria R, Leonildi A, et al. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the \"ex vivo\" synergism method. J Chemother 2004; 16:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/27\">",
"      Singh KV, Weinstock GM, Murray BE. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob Agents Chemother 2002; 46:1845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/28\">",
"      Chenoweth CE, Robinson KA, Schaberg DR. Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrob Agents Chemother 1990; 34:1800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/29\">",
"      Grayson ML, Thauvin-Eliopoulos C, Eliopoulos GM, et al. Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrob Agents Chemother 1990; 34:1792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/30\">",
"      Reynolds PE, Arias CA, Courvalin P. Gene vanXYC encodes D,D -dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174. Mol Microbiol 1999; 34:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/31\">",
"      Arias CA, Mart&iacute;n-Martinez M, Blundell TL, et al. Characterization and modelling of VanT: a novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174. Mol Microbiol 1999; 31:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/32\">",
"      Arias CA, Courvalin P, Reynolds PE. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174. Antimicrob Agents Chemother 2000; 44:1660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/33\">",
"      Leclercq R, Dutka-Malen S, Duval J, Courvalin P. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrob Agents Chemother 1992; 36:2005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/34\">",
"      Navarro F, Courvalin P. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother 1994; 38:1788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/35\">",
"      Reynolds PE. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 1989; 8:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/36\">",
"      Fines M, Perichon B, Reynolds P, et al. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 1999; 43:2161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/37\">",
"      McKessar SJ, Berry AM, Bell JM, et al. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother 2000; 44:3224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/38\">",
"      Boyd DA, Willey BM, Fawcett D, et al. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob Agents Chemother 2008; 52:2667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/39\">",
"      Lebreton F, Depardieu F, Bourdon N, et al. D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 2011; 55:4606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/40\">",
"      Guardabassi L, Agers&oslash; Y. Genes homologous to glycopeptide resistance vanA are widespread in soil microbial communities. FEMS Microbiol Lett 2006; 259:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/41\">",
"      Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993; 37:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/42\">",
"      Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33:1434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/43\">",
"      Patel R, Piper K, Cockerill FR 3rd, et al. The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal VanA vancomycin resistance gene cluster. Antimicrob Agents Chemother 2000; 44:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/44\">",
"      Guardabassi L, Christensen H, Hasman H, Dalsgaard A. Members of the genera Paenibacillus and Rhodococcus harbor genes homologous to enterococcal glycopeptide resistance genes vanA and vanB. Antimicrob Agents Chemother 2004; 48:4915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/45\">",
"      Leclercq R, Courvalin P. Resistance to glycopeptides in enterococci. Clin Infect Dis 1997; 24:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/46\">",
"      Reynolds PE, Depardieu F, Dutka-Malen S, et al. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol Microbiol 1994; 13:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/47\">",
"      Arthur M, Depardieu F, Molinas C, et al. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 1995; 154:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/48\">",
"      Mevius D, Devriese L, Butaye P, et al. Isolation of glycopeptide resistant Streptococcus gallolyticus strains with vanA, vanB, and both vanA and vanB genotypes from faecal samples of veal calves in The Netherlands. J Antimicrob Chemother 1998; 42:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/49\">",
"      Stinear TP, Olden DC, Johnson PD, et al. Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet 2001; 357:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/50\">",
"      Gu L, Cao B, Liu Y, et al. A new Tn1546 type of VanB phenotype-vanA genotype vancomycin-resistant Enterococcus faecium isolates in mainland China. Diagn Microbiol Infect Dis 2009; 63:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/51\">",
"      Yowler CJ, Blinkhorn RJ, Fratianne RB. Vancomycin-dependent enterococcal strains: case report and review. J Trauma 2000; 48:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/52\">",
"      Van Bambeke F, Chauvel M, Reynolds PE, et al. Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants. Antimicrob Agents Chemother 1999; 43:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/53\">",
"      San Millan A, Depardieu F, Godreuil S, Courvalin P. VanB-type Enterococcus faecium clinical isolate successively inducibly resistant to, dependent on, and constitutively resistant to vancomycin. Antimicrob Agents Chemother 2009; 53:1974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/54\">",
"      Shinabarger DL, Marotti KR, Murray RW, et al. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob Agents Chemother 1997; 41:2132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/55\">",
"      Leach KL, Swaney SM, Colca JR, et al. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell 2007; 26:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/56\">",
"      Meka VG, Gold HS. Antimicrobial resistance to linezolid. Clin Infect Dis 2004; 39:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/57\">",
"      Gonzales RD, Schreckenberger PC, Graham MB, et al. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 2001; 357:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/58\">",
"      Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001; 358:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/59\">",
"      Raad II, Hanna HA, Hachem RY, et al. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin. Antimicrob Agents Chemother 2004; 48:3583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/60\">",
"      Prystowsky J, Siddiqui F, Chosay J, et al. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 2001; 45:2154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/61\">",
"      Bourgeois-Nicolaos N, Massias L, Couson B, et al. Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo. J Infect Dis 2007; 195:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/62\">",
"      Marshall SH, Donskey CJ, Hutton-Thomas R, et al. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 2002; 46:3334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/63\">",
"      Mendes RE, Deshpande LM, Castanheira M, et al. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother 2008; 52:2244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/64\">",
"      Toh SM, Xiong L, Arias CA, et al. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol Microbiol 2007; 64:1506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/65\">",
"      Kehrenberg C, Schwarz S, Jacobsen L, et al. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol 2005; 57:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/66\">",
"      Arias CA, Vallejo M, Reyes J, et al. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase. J Clin Microbiol 2008; 46:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/67\">",
"      Liu Y, Wang Y, Wu C, et al. First report of the multidrug resistance gene cfr in Enterococcus faecalis of animal origin. Antimicrob Agents Chemother 2012; 56:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/68\">",
"      Diaz L, Kiratisin P, Mendes RE, et al. Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis. Antimicrob Agents Chemother 2012; 56:3917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/69\">",
"      Pogue JM, Paterson DL, Pasculle AW, Potoski BA. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2007; 28:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/70\">",
"      Herrero IA, Issa NC, Patel R. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med 2002; 346:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/71\">",
"      Dobbs TE, Patel M, Waites KB, et al. Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center. J Clin Microbiol 2006; 44:3368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/72\">",
"      Rahim S, Pillai SK, Gold HS, et al. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clin Infect Dis 2003; 36:E146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/73\">",
"      Kaatz GW, Lundstrom TS, Seo SM. Mechanisms of daptomycin resistance in Staphylococcus aureus. Int J Antimicrob Agents 2006; 28:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/74\">",
"      Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/75\">",
"      Arbeit RD, Maki D, Tally FP, et al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004; 38:1673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/76\">",
"      Poutsiaka DD, Skiffington S, Miller KB, et al. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J Infect 2007; 54:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/77\">",
"      Munoz-Price LS, Lolans K, Quinn JP. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin Infect Dis 2005; 41:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/78\">",
"      Lewis JS 2nd, Owens A, Cadena J, et al. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob Agents Chemother 2005; 49:1664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/79\">",
"      Kamboj M, Cohen N, Gilhuley K, et al. Emergence of daptomycin-resistant VRE: experience of a single institution. Infect Control Hosp Epidemiol 2011; 32:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/80\">",
"      Kelesidis T, Humphries R, Uslan DZ, Pegues D. De novo daptomycin-nonsusceptible enterococcal infections. Emerg Infect Dis 2012; 18:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/81\">",
"      Arias CA, Panesso D, McGrath DM, et al. Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 2011; 365:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/82\">",
"      Palmer KL, Daniel A, Hardy C, et al. Genetic basis for daptomycin resistance in enterococci. Antimicrob Agents Chemother 2011; 55:3345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/83\">",
"      Arias CA, Torres HA, Singh KV, et al. Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster. Clin Infect Dis 2007; 45:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/84\">",
"      Hershberger E, Donabedian S, Konstantinou K, Zervos MJ. Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology. Clin Infect Dis 2004; 38:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/85\">",
"      Canu A, Leclercq R. Overcoming bacterial resistance by dual target inhibition: the case of streptogramins. Curr Drug Targets Infect Disord 2001; 1:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/86\">",
"      Rende-Fournier R, Leclercq R, Galimand M, et al. Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145. Antimicrob Agents Chemother 1993; 37:2119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/87\">",
"      Werner G, Witte W. Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to Streptogramin A compounds. Antimicrob Agents Chemother 1999; 43:1813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/88\">",
"      Bamas-Jacques N, Lorenzon S, Lacroix P, et al. Cluster organization of the genes of Streptomyces pristinaespiralis involved in pristinamycin biosynthesis and resistance elucidated by pulsed-field gel electrophoresis. J Appl Microbiol 1999; 87:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/89\">",
"      Kehoe LE, Snidwongse J, Courvalin P, et al. Structural basis of Synercid (quinupristin-dalfopristin) resistance in Gram-positive bacterial pathogens. J Biol Chem 2003; 278:29963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/90\">",
"      Moellering RC, Linden PK, Reinhardt J, et al. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group. J Antimicrob Chemother 1999; 44:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/91\">",
"      McDonald LC, Rossiter S, Mackinson C, et al. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. N Engl J Med 2001; 345:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/92\">",
"      Korczynska M, Mukhtar TA, Wright GD, Berghuis AM. Structural basis for streptogramin B resistance in Staphylococcus aureus by virginiamycin B lyase. Proc Natl Acad Sci U S A 2007; 104:10388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/93\">",
"      Werner G, Gfr&ouml;rer S, Fleige C, et al. Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J Antimicrob Chemother 2008; 61:1182.",
"     </a>",
"    </li>",
"    <li>",
"     Clinical Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing. 15th informational supplement M100-S15. Clinical Laboratory Standards Institute; Wayne, PA 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/95\">",
"      Coque TM, Murray BE. Identification of Enterococcus faecalis strains by DNA hybridization and pulsed-field gel electrophoresis. J Clin Microbiol 1995; 33:3368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/96\">",
"      Contreras GA, DiazGranados CA, Cortes L, et al. Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococci. J Hosp Infect 2008; 70:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/97\">",
"      Dutka-Malen S, Blaimont B, Wauters G, Courvalin P. Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents Chemother 1994; 38:1675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?25/56/26506/abstract/98\">",
"      Johnson AP, Mushtaq S, Warner M, Livermore DM. Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar. J Antimicrob Chemother 2004; 53:860.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 470 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.247-9662981F41-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26506=[""].join("\n");
var outline_f25_56_26506=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H95066433\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENETICS OF RESISTANCE IN ENTEROCOCCI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      BETA-LACTAM RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Ampicillin resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      AMINOGLYCOSIDE RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      High-level resistance to streptomycin and gentamicin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TRIMETHOPRIM-SULFAMETHOXAZOLE AND CLINDAMYCIN RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      VANCOMYCIN RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Low-level resistance to vancomycin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      High-level resistance to vancomycin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Mechanism of high-level resistance to vancomycins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - VanA phenotype",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - VanB phenotype",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Vancomycin dependence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      LINEZOLID RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DAPTOMYCIN RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      QUINUPRISTIN-DALFOPRISTIN RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TIGECYCLINE RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DETECTION OF ANTIBIOTIC RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Beta-lactam resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Vancomycin resistance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Vancomycin dependence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Aminoglycoside resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Resistance differences related to species",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - E. gallinarum and E. casseliflavus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Daptomycin resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H95066433\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/470\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/470|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/62/41964\" title=\"table 1\">",
"      Ampicillin and aminoglycoside resistance in enterococci",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/5/20573\" title=\"table 2\">",
"      Phenotypes of vancomycin-resistant enterococci",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27721?source=related_link\">",
"      Epidemiology, prevention and control of vancomycin-resistant enterococci",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=related_link\">",
"      Microbiology of methicillin-resistant Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14314?source=related_link\">",
"      Treatment of enterococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16425?source=related_link\">",
"      Vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f25_56_26507="Duration illness prior to ILD";
var content_f25_56_26507=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F80410&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F80410&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Duration of interstitial lung disease prior to diagnosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Acute (days to weeks)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute idiopathic interstitial pneumonia (AIP, Hamman-Rich syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophilic pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypersensitivity pneumonitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cryptogenic organizing pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Subacute (weeks to months)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Some drug-induced ILDs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alveolar hemorrhage syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cryptogenic organizing pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Connective tissue disease (systemic lupus erythematosus or polymyositis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Chronic (months to years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic pulmonary fibrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary Langerhans cell histiocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic hypersensitivity pneumonitis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26507=[""].join("\n");
var outline_f25_56_26507=null;
var title_f25_56_26508="ACC AHA murmurs interventions";
var content_f25_56_26508=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69748&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69748&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Interventions used to alter the intensity of cardiac murmurs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Respiration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Right-sided murmurs typically increase with inspiration, while left-sided murmurs generally are louder during expiration.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Valsalva maneuver",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Most murmurs decrease in length and intensity during the Valsalva maneuver. Two exceptions are the systolic murmur of hypertrophic cardiomyopathy (HCM), which usually becomes much louder, and the systolic murmur of mitral valve prolapse (MVP), which becomes longer and often louder. Following release of the Valsalva, right-sided murmurs tend to return to baseline intensity earlier than left-sided murmurs.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Exercise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Murmurs caused by blood flow across normal or obstructed valves (eg, mitral or pulmonic stenosis) become louder with both isotonic and submaximal isometric (handgrip) exercise. Murmurs of mitral (MR) and aortic regurgitation (AR) and ventricular septal defect (VSD) also increase with handgrip exercise.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Positional changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Most murmurs diminish with standing due to reduced preload. However, the murmur of HCM becomes louder, and the murmur of MVP lengthens and often is intensified. Similarly, most murmurs become louder with prompt squatting (or usually passive leg raising), while the murmurs of HCM and MVP typically soften and may disappear.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Post ventricular premature beat (VPB) or atrial fibrillation (AF)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Murmurs originating at normal or stenotic semilunar valves increase in intensity during the cardiac cycle following a VPB or in the beat after a long cycle length in AF. In contrast, systolic murmurs due to atrioventricular valve regurgitation do not change, become softer (papillary muscle dysfunction), or become shorter (MVP).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Transient arterial occlusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transient external compression of both arms by bilateral cuff inflation to 20 mmHg greater than peak systolic pressure augments the murmurs of MR, VSD, and AR, but not murmurs due to other causes.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Discussion of amyl nitrate has been removed since the use of amyl nitrate as a provocative agent is no longer recommended.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Circulation 2008;118:e523.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26508=[""].join("\n");
var outline_f25_56_26508=null;
var title_f25_56_26509="Comparison of commonly infiltrated local anesthetics";
var content_f25_56_26509=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F56799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F56799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Comparison of commonly infiltrated local anesthetics",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Infiltration anesthetic",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Concentration (percent)",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Physiochemical properties",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Maximum allowable dose*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Maximum total dose*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Lipid:water solubility",
"       </td>",
"       <td class=\"subtitle2\">",
"        Relative potency",
"       </td>",
"       <td class=\"subtitle2\">",
"        Onset of action (min)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Duration (min)",
"       </td>",
"       <td class=\"subtitle2\">",
"        mg/kg",
"       </td>",
"       <td class=\"subtitle2\">",
"        mL/kg",
"       </td>",
"       <td class=\"subtitle2\">",
"        <p>",
"         mg",
"        </p>",
"        <p>",
"         equivalent solution volume",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"9\">",
"        Lidocaine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Without epinephrine",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2.9",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2-5",
"       </td>",
"       <td>",
"        50-120",
"       </td>",
"       <td>",
"        4-5",
"       </td>",
"       <td>",
"        0.4-0.5",
"       </td>",
"       <td>",
"        <p>",
"         300",
"        </p>",
"        <p>",
"         30 mL of 1 percent",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        With epinephrine (1:200,000)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2.9",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2-5",
"       </td>",
"       <td>",
"        60-180",
"       </td>",
"       <td>",
"        5-7",
"       </td>",
"       <td>",
"        0.5-0.7",
"       </td>",
"       <td>",
"        <p>",
"         500",
"        </p>",
"        <p>",
"         50 mL of 1 percent",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"9\">",
"        Mepivacaine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Without epinephrine",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2-5",
"       </td>",
"       <td>",
"        50-120",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        <p>",
"         300",
"        </p>",
"        <p>",
"         30 mL of 1 percent",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        With epinephrine&bull; (1:200,000)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2-5",
"       </td>",
"       <td>",
"        60-180",
"       </td>",
"       <td>",
"        5-7",
"       </td>",
"       <td>",
"        0.5-0.7",
"       </td>",
"       <td>",
"        <p>",
"         500",
"        </p>",
"        <p>",
"         50 mL of 1 percent",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"9\">",
"        Bupivacaine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Without epinephrine",
"       </td>",
"       <td>",
"        0.25",
"       </td>",
"       <td>",
"        27.5",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        5-10",
"       </td>",
"       <td>",
"        240-480",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"       <td>",
"        <p>",
"         175",
"        </p>",
"        <p>",
"         70 mL of 0.25 percent",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        With epinephrine (1:200,000)",
"       </td>",
"       <td>",
"        0.25",
"       </td>",
"       <td>",
"        27.5",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        5-10",
"       </td>",
"       <td>",
"        240-480",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        1.2",
"       </td>",
"       <td>",
"        <p>",
"         225",
"        </p>",
"        <p>",
"         90 mL of 0.25 percent",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Procaine&Delta;",
"        </strong>",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        5-10",
"       </td>",
"       <td>",
"        60-90",
"       </td>",
"       <td>",
"        7-10",
"       </td>",
"       <td>",
"        0.7-1",
"       </td>",
"       <td>",
"        <p>",
"         500",
"        </p>",
"        <p>",
"         50 mL of 1 percent",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Maximum total dose for intradermal-subcutaneous infiltration anesthesia. Lower doses and concentrations are generally required for children, debilitated patients or those with cardiac disease. Note that preparations of infiltrated local anesthestics are available in concentrations OTHER than those shown in table. Maximum allowable and maximum total volumes shown apply ONLY to the specific concentration of the preparation in table.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Not commercially available, provider must mix.",
"      <br>",
"       &Delta; Not commercially available in US or Canada.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: McCreight A, Stephan M. Local and regional anesthesia. In: Textbook of Pediatric Emergency Procedures, 2nd edition, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26509=[""].join("\n");
var outline_f25_56_26509=null;
var title_f25_56_26510="Osteochondritis dissecans knee";
var content_f25_56_26510=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69442&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69442&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Osteochondritis dissecans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is a 16-year-old with a 1-year history of knee pain. The radiograph demonstrates a well-circumscribed, dense fragment of subchondral bone demarcated from the surrounding femoral condyle or affected area by a crescent-shaped line (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Carleton University Sports Medicine Clinic.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26510=[""].join("\n");
var outline_f25_56_26510=null;
var title_f25_56_26511="2D TTE Apical 5-chamber view";
var content_f25_56_26511=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 542px\">",
"   <div class=\"ttl\">",
"    Two-dimensional transthoracic echocardiogram (2D TTE) from the apical five-chamber view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 522px; height: 171px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The apical 5 chamber view from a transthoracic echocardiogram shows the right (RV) and left (LV) ventricles, right (RA) and left (LA) atria, and the aorta (Ao).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Warren Manning, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f25_56_26511=[""].join("\n");
var outline_f25_56_26511=null;
